TABLE OF - ESAO 2016 Congressesao2016.ibib.waw.pl/userfiles/ESAO_2016_Congress_Program(1).pdf · been changing and developing very fast since the last ESAO ongress in Warsaw in 2004

2

TABLE OF CONTENTS

Table of Contents ........................................................................................................ 2

Acknowledgements ..................................................................................................... 3

Welcome Message ...................................................................................................... 4

Presidential Message .................................................................................................. 5

Boards and Committees .............................................................................................. 6

ESAO Boards and Committees .................................................................................... 7

Awards ........................................................................................................................ 8

Congress Information .................................................................................................. 9

Registration Fee and Payment Regulations .............................................................. 10

Other Regulations ..................................................................................................... 11

General Information .................................................................................................. 12

Arrivals and Departures ............................................................................................ 13

Congress Map ............................................................................................................ 14

Social Events – Opening Ceremony and Welcome Reception .................................. 15

Social Events – Networking Reception ...................................................................... 16

Social Events – Gala Dinner ....................................................................................... 17

yESAO Researchers Initiative .................................................................................... 18

Scientific Program – Overview ................................................................................. 19

Floor Plan of the Congress Venue ............................................................................. 23

Plenary Lectures, Special Symposia and Oral Sessions ............................................ 24

Poster Sessions .......................................................................................................... 43

Authors Index ............................................................................................................ 54

3

ACKNOWLEDGEMENTS

We would like to thank the following institutions and organizations for they support

Platinum Sponsor

Gold Sponsors

Silver Sponsors

Sponsors

Endorsing Institutions

4

WELCOME MESSAGE

Dear colleagues and friends,

On behalf of the Local Organizing Committee, it is our great pleasure to welcome you to the XLIII Annual Congress of the European Society for Artificial Organs, to be held at the Nalecz Institute of Biocybernetics and Biomedical Engineering (IBBE PAS), and the International Centre of Biocybernetics, Polish Academy of Sciences, Warsaw (Poland) from 14

th to 17

th

of September 2016.

The program of the Congress includes four plenary lectures on support of the diseased heart, biocompatibility, tissue engineering and technologies facilitating diabetes treatment, which will be delivered by the world-class experts: Prof. Piotr Suwalski, Prof. Jörg Vienken,

Prof. Rui L. Reis and Prof. David C. Klonoff, in the consecutive days of the Congress. Eight keynote speakers and over 75 invited speakers will report on the latest significant findings and developments in the broad field of artificial organs during 16 special symposia, the IFAO symposium, 3 ESAO Working Group symposia and ESAO Corporate Members symposium. The Program Committee of the Congress selected 120 oral and 140 poster presentations, giving scientists, clinicians, industrial partners and students from 33 countries the opportunity to present and discuss results of their work. It is worth mentioning that two of the special symposia are organized in memory of Prof. Dieter Falkenhagen and Prof. Jan M. Wojcicki, ESAO Presidents who passed away in the recent years.

The scenery of the Congress venue and the rich scientific program will create a unique atmosphere stimulating discussions and inspiring an exchange of creative ideas, bringing us closer “Towards Effective, Seamlessly integrated and Affordable Artificial Organs”, which is the theme motto of the XLIII Annual ESAO Congress. These three features of artificial organ therapy, such as the ability to effectively replace, substitute or regenerate the natural organ’s function, the seamless integration with the human body and affordability are altogether at the sharpest edge of the bioengineering revolution.

In 2016, the Annual ESAO Congress is hosted in Warsaw, the capital of Poland, for the third time. However, the city has been changing and developing very fast since the last ESAO Congress in Warsaw in 2004. Therefore, Poland´s capital has a lot to offer even to those who visited the city in the past. We are sure that you will find it very interesting and exciting to discover the new face of this bustling metropolis, experience its unique atmosphere and get to know the extraordinary history of the capital of Poland. The official tourist website of the city claims that “there are countless reasons to fall in love with Warsaw”. We hope that after staying in Warsaw on the occasion of the XLIII ESAO Congress, you will realize that it is not just an empty slogan but the real truth.

We look forward to meeting you in Warsaw to explore the fascinating area of artificial organs and to spend a good time together.

Prof. Piotr Ladyzynski Prof. Marek Darowski Congress President Honorary Congress President

5

PRESIDENTIAL MESSAGE

Dear colleagues and friends,

I am very glad to invite you to join the XLIII Congress of the European Society for Artificial Organs organized by Prof. Piotr Ladyzynski and his team from Nalecz Institute of Biocybernetics and Biomedical Engineering, and the International Centre of Biocybernetics, Polish Academy of Sciences in Warsaw, Poland from September 14–17, 2016.

This year´s motto of the Congress “Towards Effective, Seamlessly Integrated and Affordable Artificial Organs” represents a wide scale of activities, reaching from new biomaterials with improved functionality, cardiac assist, hemodialysis, apheresis, ECMO, liver support devices to the engineering of tissues and organs including fundamental studies, preclinical and

clinical investigations. In this way, the Congress will cover activities in research and development on tissue and organ support and replacements, reaching from bench to bed site.

The Congress organizers could attract the interest of people from many different countries in Europe and far beyond, collecting about 300 abstracts for oral and poster presentations. A special feature of this year´s Congress are the 19 special symposia that are organized by ESAO Working Group chairmen and other invited chair persons. Here not only themes from all areas of artificial organ support will be discussed but also emerging topics like implantable biosensors, biomimetic devices, bioartificial organs and many others.

I am also very proud to announce that the Congress organizers invited top-class speakers for keynote lectures that will certainly bring interesting new views and insights into different topics related to biocompatibility, cardiac assist devices and surgery, technologies for detecting hypoglycemia and the area of regenerative medicine.

The pre yESAO Congress that will start on September 13 provides a platform for young researchers to meet each other and to discuss their latest research also with more experienced scientists who will contribute with two tutorial lectures.

The ESAO Congress in Warsaw will also provide plenty of opportunities to discuss research results of fundamental and clinical studies with colleagues from biomedical industry, which is an important prerequisite for translating research into clinical application. In this regard, I am also looking forward to our ESAO Corporate Members Symposium where members from biomedical companies will present the latest developments in medical devices.

Those of you who do not belong to the European Society of Artificial Organs yet, are cordially invited to become a member of our society and join our activities on development of artificial organ technology, tissue engineering and regenerative medicine. We also invite all participants to submit their research results as presented during this Congress to the flagship of our society, The International Journal of Artificial Organs.

Warsaw – the capital of Poland - is a lively town with a lot of interesting and exiting sites. It is a city of many faces blending historical and socrealist buildings with post-modern skyscrapers, and has plenty more to offer like interesting museums, nice cafes and restaurants.

Finally, the hospitality of Polish people is exceptional and well known. Piotr Ladyzynski and his team have planned an exciting social program that will certainly be very pleasurable for all of us.

These are many reasons to attend the XLIII Congress of the European Society for Artificial Organs. I hope to see you there!

A warm welcome Prof. Thomas Groth ESAO President

6

BOARDS AND COMMITTEES

Honorary Congress President

Marek Darowski

Congress President

Piotr Ladyzynski

Congress Organizer

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences International Centre of Biocybernetics, Polish Academy of Sciences

Local Organizing Committee

Piotr Foltynski – Chairman Marta Baranowska Stanislawa Sabalinska Anna Ciechanowska Anna Stecka Joanna Kinasiewicz Barbara Wolff Dorota Lewinska Krzysztof Zielinski Krzysztof J. Palko

International Scientific Committee

Klaus Affeld (DE) Tim A.S. Kaufmann (DE) Rui L. Reis (PT) Angel Argilés (FR) Ulrich Kertzscher (DE) Andrea Remuzzi (IT) Steven Ash (US) Petar Kes (HR) Jacek Rozga (PL) Pedro Baptista (ES) Ashraf W. Khir (UK) Igor M. Sauer (DE) Ulrich Baurmeister (DE) Jon B. Klein (US) Heinrich Schima (AT) Andrea Buscaroli (IT) Horst Klinkmann (DE) Thomas Schlöglhofer (AT) Gerardo Catapano (IT) David C. Klonoff (US) Aleksandar Sikole (MK) Anna Ciechanowska (PL) Piotr Ladyzynski (PL) Simon J. Sonntag (DE) Peter Czermak (DE) Cecile Legallais (FR) Dimitrios Stamatialis (NL) Marek Darowski (PL) Dorota Lewinska (PL) Bernd G. Stegmayr (SE) Juan F. del Cañizo (ES) Adam Liebert (PL) Gustav Steinhoff (DE) Arianna Di Molfetta (IT) Bengt Lindholm (SE) Ulrich Steinseifer (DE) Sunny Eloot (BE) Roman Maniewski (PL) Maria Giovanna Trivella (IT) Giuseppe Faggian (IT) Joao F. Mano (PT) Wladyslaw Torbicz (PL) Gianfranco Ferrari (IT) Ares K. Menon (DE) Markus Storr (DE) Piotr Foltynski (PL) Bart Meyns (BE) Tom Verbelen (BE) Birgit Glasmacher (DE) Francesco Moscato (AT) Jörg Vienken (DE) Ludomira Granicka (PL) Khosrow Mottaghy (DE) Beat Walpoth (CH) Thomas Groth (DE) Zbigniew Nawrat (PL) Jacek Waniewski (PL) Joachim Jankowski (DE) Nuno M. Neves (PT) Viktoria Weber (AT) Erik A. Johannessen (NO) Dorota G. Pijanowska (PL)

7

ESAO BOARDS AND COMMITTEES

ESAO Board

President: Thomas Groth (DE) President Elect: Cecile Legallais (FR) Past President: Bernd G. Stegmayr (SE) Honorary President: Horst Klinkmann (DE) Treasurer: Ulrich Kertzscher (DE) General Secretary: Sunny Eloot (BE) Honorary Board Member: Sergio Stefoni (IT) Co-opted Board Member: Birgit Glasmacher (DE) Rui L. Reis (PT) Heinrich Schima (AT)

ESAO Governors

Gerardo Catapano (IT) Tim A. S. Kaufmann (DE) Marek Darowski (PL) Ashraf W. Khir (UK) Arianna Di Molfetta (IT) Bengt Lindholm (SE) Giuseppe Faggian (IT) Francesco Moscato (AT) Joachim Jankowski (DE) Maria Giovanna Trivella (IT)

ESAO Working Groups

Apheresis and Adsorption Chairman: Bernd G Stegmayr (SE), [email protected]

Bioartificial Organs Chairman: Dimitrios Stamatialis (NL), [email protected]

Education

Chairman: Aleksandar Sikole (MK), [email protected] Co-Chairman: Rafael Ponikvar (SI), [email protected]

Heart Support Chairman: Ulrich Steinseifer (DE), [email protected]

Liver Support Chairman: Igor Sauer (DE), [email protected]

Tissue Engineering Chairman: Nuno Neves (PT), [email protected]

Uremic toxins

Chairman: Àngel Argilés (FR), [email protected] Co-Chairman: Joachim Jankowski (DE), [email protected]

ESAO Corporate Members

Chairmen: Markus Storr (DE) and Ares K. Menon (DE)

yESAO

Chairman: Tom Verbelen (BE) Co-Chairman: Simon Sonntag (DE) Webpage: http://www.yesao.org

8

AWARDS

ESAO-Wichting Research Award

The Annual ESAO-Wichtig Awards is the most important award for the ESAO to acknowledge the scientific achievements of young scientists. The award is given to the best peer-reviewed publication of scientists younger than 38 years working in the field of artificial organ research. A call for submission of candidate publications and authors has been issued in the ESAO web-site and in the International Journal for Artificial Organs (IJAO). A committee of scientist members of the ESAO will rate the submitted and will select the winner. The winner will receive a check of 2,500 Euro and a certificate during the Opening Ceremony of the Congress, and will be given the possibility to briefly present the work done during the Congress. The ESAO is thankful to Wichtig International for sponsoring this award.

ESAO Poster Awards

Three Poster Awards (500, 300 and 200 Euro respectively) will acknowledge the authors of the best posters. An ESAO Committee will select the awardees based on poster scientific content and graphic presentation. The Awards will be notified during the Closing Ceremony the Congress.

ESAO Innovation Award

The ESAO innovation award (500 Euro) will acknowledge the most innovative abstract presented. The winner will be selected by an ESAO Committee, based on the abstract content and presentation. The Award will be notified during the Closing Ceremony of the Congress.

ESAO PhD Award

This ESAO award is meant for young researches who recently finalized their PhD. The award mainly aims at encouraging PhD students to make their work visible on an international level, already from the start of their PhD. Hence, next to the appreciation of the finalized PhD book by a committee of ESAO board members, also the international impact of the applicant’s CV will be rated. Awardees will be handed in a “Certificate of Recognition of Excellence” during the Opening Ceremony of the Congress and will be given the opportunity to briefly present their PhD work in a special session.

yESAO Exchange Program Award

This yESAO award gives students possibility to experience research in different European research Laboratories, offering a grant of 500 Euro for each participating research. This year, the yESAO Exchange Program Award will be handed in during the Opening Ceremony of the Congress to the following winners:

Indra Müller (Department of Cardiovascular Engineering, RWTH Aachen, Germany) and Philipp Aigner (Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria) for research on “Comparison and iImprovement of cardiac and vascular mock-up components for flow visualization”,

Michela Bozzetto (IRCSS - Istituto di Ricerche Farmacologiche “Mario Negri”, Italy) and Floris Vanommeslaeghe (Ghent University Hospital, Belgium) for research on “Computational modeling for surgical planning of arteriovenous fistula for hemodialysis”,

Alejandro Garcia Garcia (BioMechanics and BioEngineering laboratory, Université de Technologie de Compiègne (UTC), France) and Fedaa Al Halabi (Institute for Multiphase Processes, Leibniz Universitaet Hannover, Germany) for research on “Coaxially electrospun and directional solidified scaffolds for bone and vascular tissue engineering”.

The awardees will be given the opportunity to briefly report on their experience in a special session.

9

CONGRESS INFORMATION

Congress Secretariat

Prof. Piotr Ladyzynski Nalecz Institute of Biocybernetics and Biomedical Engineering

4, Trojdena Str., 02-109 Warsaw, Poland. Phone: +48 22 5925942, fax: +48 22 6597030

e-mail: [email protected]

Congress Venue

The Congress will be held at the premises of the Nalecz Institute of Biocybernetics and Biomedical Engineering and International Centre of Biocybernetics, Polish Academy of Sciences, 4 Księcia Trojdena Street, Warsaw, Poland. The Institute is located at the corner of Księcia Trojdena Street and Pawińskiego Street. The main entrance to the Institute is located at Pawińskiego Street and the entrance to the paid parking is located at Księcia Trojdena Street (behind the barrier). The GPS coordinates of the Congress Venue are as follows: N 52° 12’ 24’’ E 20° 58’ 42’’

Official Language

English will be the official language of the Congress. No parallel translation will be provided.

Registration and Information During the Congress

Delegates are kindly requested to register at the Central Reception located in the Congress venue at the Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, at the beginning of the Congress. Participants will be able to collect their badge and Congress documentation. Central Reception will be open at the following hours:

Wednesday, September 14th

, 12:00 - 17:00 Thursday, September 15

th, 08:00 - 18:00

Friday, September 16th

, 08:00 - 18:00 Saturday, September 17

th, 08:00 - 15:00

10

REGISTRATION FEE AND PAYMENT REGULATIONS

Registration Fee

Different categories of registration fee have been available for Congress participants.

Category Early Bird Fee (before June 15

th, 2016)

Regular Fee (after June 15

th, 2016)

EURO EURO

ESAO member 350 400

ESAO member (reduced fee*) 250 300

Senior ESAO member 150 200

ESAO non-member 400 450

ESAO non-member (reduced fee*) 350 400

MSc Student and PhD student** 150 200

One-day registration 150 200

Accompanying person 100 150

Gala Dinner 50 50

* for participants from Central and Eastern Europe and from low and lower-middle income countries (Gross National Income per capita less than 4 125 USD),

** a certificate from university should be provided

Payment Regulations

Payments can be made by bank transfer or by payment card.

Payments are available for registered users only.

Registration can be made using Registration on-line at http://esao2016.ibib.waw.pl

Bank transfer

Bank transfer payment should be made to the following account:

Account owner: Instytut Biocybernetyki i Inzynierii Biomedycznej im. Macieja Nalecza Polskiej Akademii Nauk, ul. Ks. Trojdena 4, 02-109 Warszawa, POLAND

Bank: BGK

IBAN / Account No: PL07113010170020144708200027

SWIFT: GOSKPLPW

While paying by bank transfer, please:

ensure that all the bank charges are paid by the participant, make sure that your name appears on the payment,

send the copy of bank transfer receipt to the Congress Secretariat either by e-mail or by fax.

Card payment

Card payment is available using the following Payment Cards: Visa, VisaElectron, Master Card, Master Card Electronic, Maestro.

Online transaction are supported by eCard S.A.

http://esao2016.ibib.waw.pl/

11

OTHER REGULATIONS

Registration fee for participants includes:

Congress Bag, Abstract Book, Congress Badge, Opening Ceremony and Welcome Reception on September 14th,

Networking Reception on September 15th, Admission to all plenary sessions, symposia, poster sessions and exhibition,

Lunches on September 15th and 16th, and Farewell Lunch on September 17th and refreshments during breaks.

Registration fee for accompanying persons includes:

Congress Badge and Admission to the Congress venue, Opening Ceremony and Welcome Reception on September 14th,

Networking Reception on September 15th, Lunches on September 15th and 16th, and Farewell Lunch on September 17th and refreshments during breaks.

Receipts and VAT Invoices

Fees listed in the fee table above are inclusive of tax and include VAT where applicable. The Organizer will issue a VAT invoice for the Buyers, provided that all information of the Buyer needed for issuing of the VAT invoice will be given by the participants before making the payment (using 'Registration on-line').

Cancellation

Notification of cancellation must be made in writing to the Congress Secretariat. Cancellation before July 20th, 2016 - a refund of 90% will be made. Cancellation before August 10th, 2016 - a refund of 50% will be made. Cancellation after August 20th, 2016 - no refund will be made.

All refunds will be made after the Congress. In case of bank transfer payment, the reimbursement will be transferred directly to the account that was used to make the payment. In case of card payment, the reimbursement will be transferred directly to the card payment account.

Returns

RETURNS ARE NOT ACCEPTED due to the nature of the services ordered by the participants.

Processing of the Personal Data

Personal data of participants will be processed by the Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences (the Organizers) with its seat in Warsaw (Poland), 02-109, at 4 Księcia Trojdena Street for the purpose of their participation in XLIII Annual Congress of the European Society for Artificial Organs, including processing of payment of the registration fees.

Participants acknowledge that they have the right to access and rectify abovementioned personal data, as defined in the Act of August 29, 1997 on the Protection of Personal Data (Journal of Laws of 2014, item 1182, with amendments).

Submitting personal data is voluntary, but necessary to accomplish participation in the abovementioned Congress.

Warranty Disclaimer

All the best endeavors will be made by Organizers to implement the program of the ESAO 2016 Congress as it will be announced here. However, no warranty is given whatsoever that the final program will be in full agreement with the announced one. The Organizers reserve the right to alter or cancel, without prior notice, any of the arrangements, timetables, plans or other items relating directly or indirectly to the Congress, for any reasons beyond their reasonable control.

12

GENERAL INFORMATION

Passports and Visas

Foreign visitors from outside the European Union must possess a passport valid for at least the next 6 months. Some congress participants may require visa in order to enter Poland. Please check with your local Polish Consulate or Embassy for details regarding visa and entry requirements.

Liability

The Congress Secretariat and Organizers cannot accept liability for personal accidents, loss of belongings or damage to private property of participants, students and accompanying persons, either during or directly arising from the ESAO 2016 Congress. Participants should make their own arrangements with respect to health, travel and property insurance before they depart from their country.

Currency and Credit Cards

The currency unit in Poland is the Polish Złoty (zł or PLN) which is subdivided into 100 grosze (gr). The current exchange rate to Euro and US Dollar can be checked at http://www.oanda.com/converter/classic (choose PLN as the Polish currency code). In August 2016 it was about 4.35 PLN for 1 EUR. Delegates may change foreign currency and travelers checks at several banks located in the city center as well as in many exchange bureaus, at the railway station, at the airport or in many others places. International credit cards are widely accepted in hotels, restaurants, cash machines and shops.

Electricity

Electricity supply is 230 V / 50 Hz.

Climate and Clothing

The weather in September in Warsaw is usually warm and pleasant, however the evenings might be sometimes quite cold. The average daytime temperature varies from 15 degrees to 18 degrees of Celsius. There is a possibility of rain, so an umbrella, light raincoat and comfortable shoes are advisable.

Shopping

Most shops (except for food stores) are open from 11:00 until 19:00. Some department stores may open earlier or close later on weekdays as well as on Saturdays and Sundays.

Polish craftwork is fascinating. Polish souvenirs include glass, hand-woven baskets, paper cut-outs and crystal. One of the most popular souvenirs is amber from the Baltic Sea. Each individual piece can be fashioned into a pendant, ring, bracelet, or earrings. Most highly prized is amber with a prehistoric insect preserved inside, though it is a rare find. Poland is also known for its silver jewellery, which is sometimes combined with amber to create uniquely Polish pieces.

Food

Poles are known for their hospitality and love of food. Polish meals offer a wide selection ranging from fresh game in season to Baltic herring. Red beet soup or borsch, is well-known, as are Polish sausages (kielbasa) and stuffed cabbage (gołąbki). Dumplings (pierogi) come stuffed with meat, potatoes, blueberries, or sauerkraut and mushrooms. Bigos is a stew of meat and sauerkraut, while roast duck comes stuffed with apples. For dessert, try pastries with poppy seeds, or perhaps a Polish donut filled with preserved fruit (pączek). In the late summer, you can try delectable strawberries, blueberries and cherries.

http://www.oanda.com/converter/classic

13

ARRIVALS AND DEPARTURES

By Air

Congress Venue is 5 km away from Warsaw Chopin Airport “Okęcie”. It can be reached from Warsaw Chopin Airport by taxi (cost 20-40 Polish Złoty) or by bus no. 175 (the bus stop is located in front of the arrivals hall). A bus ticket for 20 min costs 3.40 Polish Złoty and for 75 min – 4.40 Polish Złoty. It is advisable to buy a ticket before getting to a bus because ticket machines are not present in all the buses. Usually the 20 min ticket is enough if there is no heavy traffic. You should get off the bus at UNIWERSYTET MEDYCZNY 02 stop, cross Żwirki i Wigury Street and walk 600 m to the West along Księcia Trojdena Street. Congress Venue is the last group of buildings on the right just at the corner of of Księcia Trojdena Street and Adolfa Pawińskiego Street. Bus no. 175 can be also used to get to the center of the city (75 min ticket is necessary). There is also a railway connection from Warsaw Chopin Airport “Okęcie” to Warsaw Central Railway Station (Warszawa Centralna).

By Rail

Warsaw Central Railway Station (Warszawa Centralna) is located in the city center at 54 Jerozolimskie Avenue (Aleje Jerozolimskie). Congress Venue can be reached from Warsaw Central Railway Station by taxi (cost 20-30 Polish Złoty) or by tram no. 9 or 7 in the West direction to the Ochota district. The tram stop located in the middle of Aleje Jerozolimskie can be reached using underpass. A tram ticket for 20 min costs 3.40 Polish Złoty and for 75 min – 4.40 Polish Złoty. It is

advisable to buy a ticket before getting to a tram because ticket machines are not present in all the trams. Usually the 20 min ticket is enough if there is no heavy traffic. You should get off the tram at HALE BANACHA 02 stop at the Grójecka Street and then walk 300 m to the East to the Congress Venue.

By Road

For those traveling from the West, North or South, Warsaw can be reached by car using A2 highway and then S2 Warsaw beltway. You should head to the South (towards Kraków), take Aleja Krakowska exit, turn left onto Krakowska Avenue (Aleja Krakowska) towards city center, after 5 km turn right onto Dickensa Street, after 300 m turn left onto Pawińskiego Street, after 300 m turn right onto Księcia Trojdena Street and then after 100 m turn left into the first gate to the paid parking lot in front of the Congress Venue.

Photo: http:// www.lotnisko-chopina.pl

Photo: Radek Kołakowski, http://pl.wikipedia.org

Photo: Łukasz Jóźwiak, Ministry of Transport, Construction and Marine Economy

14

CONGRESS MAP

The interactive map is available at: http://esao2016.ibib.waw.pl/index.php?id=17

Congress Venue

Opening Ceremony and Welcome Reception,

September 14th, 19:00 - 22:00

Networking Reception,

September 15th, 18:15-21:00

Gala Dinner,

September 16th, 19:45-22:00

The Westin *****

Radisson Blu Sobieski Hotel, Warsaw

Novotel Warszawa Centrum ****

Polonia Palace ****

Mercure Warszawa Grand ****

Novotel Warszawa Airport ****

Ibis Warszawa Reduta ***

MDM City Centre ***

Metropol ***

Campanile**

1

2

3

4

5

6

7

8

9

10

OC

NR

http://esao2016.ibib.waw.pl/index.php?id=17

15

SOCIAL EVENTS

Opening Ceremony and Welcome Reception

Wednesday, September 14th, 2016, 19:00-22:00

Technicians’ Association House of the Head Technical Organization (Warszawski Dom Technika NOT), 3/5 Czackiego Street

The Opening Ceremony and Welcome Reception will take place in the Technicians’ Association House of the Head Technical Organization. The Technicians’ Association was founded in Warsaw in 1898, and the construction of its Czackiego Street office started in 1903, and was designed by Jan Fijałkowski. The neo-baroque building was given its appearance partly due to the facade sculptures by Zygmund Otto. The figures are of Daedalus, Icarus and Archimedes, and a woman of radium rays, who symbolizes the past and the future. Perched on a cartouche, she is supported by seated figures of women, bearing the inscription ‘Artibus Technicis MXMIV’. Inside the stairwell there was an ornate ceiling,

showing people going through the fire of revolution and headed toward a better future. Between 1913-1914 a wing was added to the building, and during World War I, the main halls were opened for use by the hospital. As a result of World War II, Tech House was burned; though the bearing walls were preserved and part of the main staircase survived, the rich interior and stucco did not survive the war. The restored building was opened in 1949. Currently, it houses many groups, and acts as the headquarters for the Head Technical Organization.

The scientific program of the Opening Ceremony is outlined in the Congress Program – Overview. To make the beginning of the Congress more attractive and memorable the scientific content of the ceremony will be complemented with the artistic one. During the Opening Ceremony, Agnieszka Flis (Agnes Violin) will perform . Agnieszka Flis (Agnes Violin) is a violinist, precursor and performer of spectacular music shows, where she plays the diamond violin. Keeping abreast of the times Agnes Violin has focused on fusion of her classical skills as a violinist and the latest world trends of creating artistic sensations. After graduating from the Academy of Music in Łódź she was linked to the Łódź Philharmonic and a few ensembles. However, continuously searching for possibilities of new music interpretation she had chosen a solo carrier. Agnes Violin has played concerts in United States, Canada, Japan, China and many other countries gaining rich stage experience. In Poland, she has partnered a few well known artists. Agnes Violin is a versatile musician, who can perform different musical styles, starting with classical music, through jazz, folk and ending with improvisation and club music. Show on the Diamond Electric Violin is composed of very dynamic, original, masterly and diversified arrangements of pop, musical and movie tunes.

Text and photos: http://www.warsawtour.pl

Text and photos: http://www.warsawtour.pl

Photo: http://agnes-violin.muzzo.pl

16

SOCIAL EVENTS

Networking Reception

Thursday, September 15th, 2016, 18:15-20:30

Exhibition Hall at the Congress Venue, 4 Księcia Trojdena Street

After the completion of the scientific sessions of the first day of the Congress all participants are invited to gather in the Exhibition Hall (Lunch Area). During the Networking Reception you will have the possibility to mingle with other congress participants, meet old friends and make new contacts in an informal atmosphere. Snacks and drinks will be served to make the evening more enjoyable and to facilitate the exchange of views. Among other delicacies, you will have the opportunity to taste famous Polish potato pancakes, which will be prepared right before your eyes, and to try different types of Polish beers.

This event is free of charge for all registered congress participants and accompanying persons.

17

SOCIAL EVENTS

Gala Dinner

Friday, September 16th, 2016, 19:45-22:00

Lecture Hall at the Central Agricultural Library (Centralna Biblioteka Rolnicza), 66 Krakowskie Przedmieście Street

The building of the Central Agricultural Library is located in the heart of Warsaw, just 100 m from the Royal Castle. It was founded in 1454 as a monastery. During the "Swedish Deluge" a monastery was burned. After the expulsion of the Swedes monastery was rebuilt and decorated in the baroque style. Secular functions monastery building dates back to the first years after the partition of Poland in 1772. First, the Prussians dedicate part of the monastery at the guardhouse. During the stay of Napoleon monastery served as a military hospital. The monastery was then close to ruin. Once again became a place of public events during the January Uprising in 1863 that gave rise to the liquidation of the monastery

in 1865. The owner of the buildings post-monastery has become the Museum of Industry and Agriculture, which was founded in Warsaw in 1875. After the First World War, the museum lost some importance but it has been developing further. In 1939, during the bombing of Warsaw Museum building, along with the collection was destroyed. Rebuilt after the war, in 1955, it was intended for the Central Agricultural Library. It is a scientific library of the Ministry of Agriculture and Rural Development. It collects literature in the field of agricultural science, horticulture, animal husbandry, fisheries, veterinary medicine, food industry, agricultural technology, environmental protection, forestry, politics and economics of agriculture and related sciences. Book Library - has about 380 thousand ox. Publications. In 2005, the Library celebrated its 50

th

anniversary. During the Gala Dinner a show of a Polish Folk Song and Dance Ensemble Polski Łan will take place. Polski Łan was formed by Zbigniew Jasiński in 2005 with professional dancers and musicians who have contributing to the high artistic quality of the ensemble and its continuous development. Polski Łan has in its repertoire brilliantly executed Polish national dances: krakowiak, mazurek, oberek, polonaise, kujawiak as well as folk dances and songs from different regions of the country. Original and beautiful costumes and a music band playing traditional folk instruments emphasize the character of the performed songs and dances. Choreography and music arrangements result from collaboration with renowned artists who have been

associated with this genre of art for a long time. Dancing, singing, games and competitions with the audience will carry the spectators into a colorful and joyful world of Polish folklore.

Photo: http://cateringamfitrion.blogspot.com

Text and photo: http://www.cbr.edu.pl

Text and photo: http://www.polskilan.pl

18

The event is co-sponsored by the International Centre of Biocybernetics

19

SCIENTIFIC PROGRAM – OVERVIEW

20


21


22


23

FLOOR PLAN OF THE CONGRESS VENUE

Exhibition Legend

1. HeartWare 2. Infomed

3. Fresenius Medical Care 4. em-tec

5. Berlin Heart 6. 3M

7. Wichtig

1

2

3

4

6

5

7

24

PLENARY LECTURES, SPECIAL SYMPOSIA AND ORAL SESSIONS

WEDNESDAY, September 14th

Plenary Lecture 1

Opening Ceremony Hall

Chairmen: Thomas GROTH, Halle, Germany, Piotr LADYZYNSKI, Warsaw, Poland

19:30 PL1 IN THE SEARCH OF SUPPORT OF DISEASED HEART

Suwalski P Clinic of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration in Warsaw, Warsaw, Poland

THURSDAY, September 15th

Oral Session OS1 Blood Pump Development O1-O6

Lecture Hall A

Chairmen: Graham FOSTER, Swansea, UK, Ulrich STEINSEIFER, Aachen, Germany

8:30 O1 MINIATURIZATION AND OPTIMIZATION OF A VENTRICULAR ASSIST DEVICE

Hallier S1, Torner B1, Wisniewski A2, Müller J2, Peter N2, Wurm F1 1 Institute of Turbomachines, University of Rostock, Rostock, Germany; 2 Berlin Heart GmbH, Berlin, Germany

8:45 O2

DESIGN CHANGES OF THE VENTRICULAR ASSIST DEVICE SPUTNIK

Selishchev S, Telyshev D

Biomedical systems, National Research University of Electronic Technology, Moscow, Russian Federation

9:00 O3 CURRENT AND SPEED RESPONSE OF THE HVAD IN SINGLE AND DUAL STATOR CONFIGURATION

Maw M1, Aigner P2, Schima H3, Moscato F1 1 Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; 2 Ludwig-Boltzmann-Cluster for Cardiovascular Research, Vienna, Austria; 3 Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria

9:15 O4

INVESTIGATION OF THE PERMANENT MAGNETIC BEARINGS FOR RELIGA HEART ROT CENTRIFUGAL BLOOD PUMP

Altyntsev I, Kurtyka P, Darłak M, Kustosz R

Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland

9:30 O5 BENCHMARK OF CENTRIFUGAL IMPELLER DESIGNS USING COMPUTATIONAL FLUID DYNAMICS: CLINICAL VAD VS. INDUSTRIAL PUMP

Boës S1, Wiegmann L2, Ochsner G1, de Zélicourt D2, Meboldt M1, Kurtcuoglu V2,3, Schmid Daners M1 1 Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland; 2 The Interface Group, Institute of Physiology, University of Zurich, Zurich, Switzerland; 3 Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

9:45 O6

TIME RESOLVED 3D-VELOCITY MEASUREMENTS IN A SCALED UP HEARTMATE II BLOOD PUMP MODEL

Schuele C, Menzen C, Affeld K, Kertzscher U

Biofluid Mechanics Laboratory, Charite - Universitaetsmedizin Berlin, Berlin, Germany

Plenary Lectures, Special Symposia and Oral Sessions Thursday, September 15th

25

Oral Session OS2 Vascular Access and New Perspectives O7-O12

Lecture Hall B

Chairmen: Andrea REMUZZI, Milan, Italy, Krzysztof JOZWIK, Lodz, Poland

8:30 O7

COMPUTER SIMULATION OF THE ARTERIOVENOUS FISTULA MATURATION

Jodko D, Obidowski D, Reorowicz P, Jozwik K

Institute of Turbomachinery, Lodz University of Technology, Lodz, Poland

8:45 O8

INFLUENCE OF THE ARTERIAL NEEDLE DIRECTION ON ACCESS FLOW MEASUREMENT

Lopot F, Vermirovska J, Svara F, Polakovic V

Department of Medicine, General University Hospital, Praha, Czech Republic

9:00 O9

CLINICAL USE OF AVF.SIM SYSTEM FOR SURGICAL PLANNING OF ARTERIOVENOUS FISTULA FOR HEMODIALYSIS

Bozzetto M1, Rota S2, Vigo V3, Casucci F3, Lomonte C3, Morale W4, Senatore M5, Tazza L6, Lodi M7, Remuzzi G2, Remuzzi A1 1 Bioengineering Department, IRCSS - Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy; 2 Unit of Nephrology and Dialysis, ASST Papa Giovanni XXIII, Bergamo, Italy; 3 Unit of Nephrology and Dialysis, Ente Ecclesiastico Ospedale F. Miulli, Acquaviva delle Fonti (BA), Fonti, Italy; 4 Unit of Nephrology and Dialysis, A.O. Cannizzaro, Catania, Italy; 5 Unit of Nephrology and Dialysis, Ospedale Annunziata, Cosenza, Italy; 6 Department of Urology and Nephrology, Catholic University, Rome, Italy; 7 Unit of Nephrology and Dialysis, Ospedale Santo Spirito, Pescara, Italy

9:15 O10

HEALTH RELATED QUALITY OF LIFE IN HEMODIALYSIS PATIENTS WITH DIFFERENT NUMBER OF PREVIOUS ARTERIO-VENOUS FISTULA THROMBOSIS

Gelev S, Gerasimovska V, Dejanov P, Selim G, Dzekova P, Trajceska L, Sikole A

Department of Nephrology, University Clinic, Skopje, The Former Yugoslav Republic of Macedonia

9:30 O11

CHANGING PERSPECTIVES IN EXTRACORPOREAL TREATMENTS – FROM PASSIVE MACHINE MONITORING TO ACTIVE PHYSIOLOGIC PATIENT DATA

Kleinekofort W

Department of Engineering, RheinMain University of Applied Sciences, Wiesbaden, Germany

9:45 O12

CHALLENGE TO THE NEXT STAGE OF ARTIFICIAL KIDNEY

Matsuda K1, Moriguchi T1, Yamane T2, Kokubo K3, Yamamoto K4 1 Emergency and Critical Care Medicine, University of Yamanashi School of Medicine, Yamanashi, Japan; 2 Mechanical Engineering, School of Engineering, Kobe University, Kobe, Japan; 3 Medical Engineering and Technology, Kitasato University School of Allied Health Sciences, Kanagawa, Japan; 4 Medical Engineering, Kawasaki University of Medical Welfare, Kurashiki, Japan

Oral Session OS3 Biomaterials Synthesis and Characterization O13-O18

Lecture Hall C

Chairman: Gloria GALLEGO-FERRER, Valencia, Spain, Andrzej CHWOJNOWSKI, Warsaw, Poland

8:30 O13

DIAMOND-LIKE-CARBON COATING FOR EXTENDED POLYTETRAFLUOROEHYLENE: POTENTIAL FOR EXPANSINO OF APPLICATION TO THE MEDICAL FIELD.

Fujii Y1, Oozawa S1, Osaka D1, Nakatani T2, Uchida H3, Sano S1 1 Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan; 2 Research Institute of Technology, Okayama University of Science, Okayama, Japan; 3 Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

8:45 O14

CARDIOVASCULAR SCAFFOLDS FABRICATED FROM BLOOD PROTEIN SOLUTIONS VIA ELECTROSPINNING

Mueller M1, Dreyer L1, Repanas A1, Krolitzki B1, Knigge S1, Wang I2, Pfeiffer D2, Glasmacher B1 1 Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany; 2 Institute for Cell Biology, Histology and Embryology, Medical University Graz, Graz, Austria

9:00 O15

REDUCING WATER TRANSMISSION OF DYNAMICALLY LOADED POLYURETHANE BY MULTILAYER BARRIER COATINGS APPLIED BY PLASMA-ENHANCED CHEMICAL VAPOR DEPOSITION (PECVD)

Lierath C

Deptartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany

9:15 O16

LIFETIME PREDICTION FOR THE DESIGN OF A NEW POLYMERIC HEART VALVE PROSTHESIS

Serrani M1, Brubert J1, Stasiak J1, De Gaetano F2, Costantino M2, Moggridge G1 1 Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK; 2 Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milano, Italy

9:30 O17

CLOSER LOOK INTO EXPERIMENTAL SET-UPS OF THE HIGHLY COMPLEX MAGNESIUM DEGRADATION

Knigge S, Evertz F, Glasmacher B

Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany

9:45 O18

IN VIVO BIOCOMATIBILITY STUDY OF AN INNOVATIVE ELASTOMER FOR LONG TERM IMPLANTS APPLICATION

Zawidlak-Węgrzyńska B1, Ścigała P2, Janiczak K1, Gawlikowski M1, Cieśla P1, Kustosz R1, Gonsior M1, El Fray M3, Piegat A3 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Emergency and Specialty Animal Medical Center, Piekary Slaskie, Poland; 3 Polymer Institute, Biomaterials and Microbiology Technologies Dept., West Pomerania University of Technology, Szczecin, Poland


26

Oral Session OS4 Tissue Engineering. Bone and cartilage, O19-O24

Lecture Hall D

Chairmen: Dorota LEWINSKA, Warsaw, Poland, Gerardo CATAPANO, Rende, Italy

8:30 O19

2D TRANSPORT MODEL OF rPBBs FOR BONE TE PREDICTS THAT RADIAL FLUX UNIFORMITY CONTROLS O2 DISTRIBUTION IN CELL ACTIVITY-DEPENDENT FASHION

Donato D1, Falvo D'Urso Labate G2, Debbaut C1, Segers P1, Catapano G2 1 IbiTech-BioMMeda, Ghent University, Ghent, Belgium; 2 Department of Environmental and Chemical Engineering, University of Calabria, Rende, Cosenza, Italy

8:45 O20

TIME EVOLUTION OF OXYGEN CONCENTRATION PROFILES AS CELLS GROW AND DIFFERENTIATE IN rPBBs FOR BONE TE FROM A 3D TRANSIENT TRANSPORT MODEL

Falvo DUrso Labate G1, Torchia F1, Debbaut C2, Segers P2, Catapano G1 1 Department of Environmental and Chemical Engineering, University of Calabria, Rende, Cosenza, Italy; 2 IbiTech - BioMMeda, Ghent University, Ghent, Belgium

9:00 O21

OSTEOGENIC DIFFERENTIATION OF RAT BONE MARROW STROMAL CELLS ENCAPSULATED INTO PHOTOCROSSLINKED COLLAGEN-LIKE POLYPEPTIDE HYDROGELS

Nurlidar F, Yamane K, Kobayashi M, Terada K, Ando T, Tanihara M

Materials Science, Nara Institute of Science and Technology, Nara, Japan

9:15 O22

BONE TISSUE ENGINEERING WITH POLYCAPROLACTONE/HYDROXYAPATITE BIOMIMETIC SCAFFOLDS

Garcia Garcia A1, Schlatter G2, Anne H2, Egles C1, Bedou F3, Legallais C1 1 BMBI UMR 7338, Université de Technologie de Compiègne, Compiègne, France; 2 UMR 7515 ICEPEES, Université de Strasbourg, Strasbourg, France; 3 UMR 7337 Laboratoire Roberval, Université de Technologie de Compiègne, Compiègne, France

9:30 O23

MACROPOROUS PLA CONSTRUCT SUPPORTING THE OSTEOINDUCTIVE POROUS CHITOSAN-HYDROXYAPATITE HYDROGEL FOR BONE TISSUE ENGINEERING

Rogina A1, Pribolšan L2, Gómez-Estrada L3, Gallego Ferrer G4, Marijanović I2, Ivanković M1, Ivanković H1 1 Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia; 2 Faculty of Science, University of Zagreb, Zagreb, Croatia; 3 Ikasia Technologies SL, c/Zamora 2, 46100 Burjassot, Valencia, Spain; 4 Center for Biomaterials and Tissue Engineering (CBIT), Universitat Politècnica de València, Valencia, Spain

9:45 O24

BIODEGRADABLE MICROSPHERES FOR ARTICULAR CARTILAGE REGENERATION

Sancho-Tello M1, Milián L1, Zurriaga J2, Forriol F3, Martín de Llano J1, Mínguez M4, Carda C1 1 Departamento Patología, Universidad de Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain; 2 Servicio Traumatología, Hospital Clínico Universitario de Valencia, Valencia, Spain; 3 Servicio Traumatología, Hospital Clínico Universitario de Valencia; ERESA, Valencia, Spain; 4 Servicio Traumatología, Hospital Clínico Universitario de Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain

Plenary Lecture 2

Lecture Hall A

Chairman: Horst KLINKMANN, Rostock, Germany

10:10 PL2 LESSONS LEARNT FROM THREE DECADES OF BIOCOMPATIBILITY RESEARCH

Vienken J Usingen, Germany

Oral Session OS5 Blood Trauma in VADs O25-O30

Lecture Hall A

Chairmen: Heinrich SCHIMA, Vienna, Austria, Leonid GOUBERGRITS, Berlin, Germany

11:00 O25

CHARACTERIZATION OF BLOOD DAMAGE UNDER DYNAMIC AND STATIC CONDITIONS USING MULTIPLE HEMOLYSIS MARKERS

Wiegmann L1, de Zélicourt D1, Speer O2, Kurtcuoglu V3 1 The Interface Group, Institute of Physiology, University of Zurich, Zurich, Switzerland; 2 Erythrocyte laboratory, University Children's Hospital Zurich, Zurich, Switzerland; 3 The Interface Group, Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

11:15 O26

THE INFLUENCE OF OPERATING CONDITIONS ON THE FLOW FIELD IN A ROTARY BLOOD PUMP Thamsen B, Gaebler J, Affeld K, Kertzscher U


11:30 O27

ABILITIES OF ULTRASONIC METHODS APPLICATION TO MICRO-EMBOLUS DETECTION IN MECHANICAL HEART SUPPORTING SYSTEMS

Gawlikowski M1, Lewandowski M2, Jaworek M1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, Poland

11:45 O28

INFLUENCE OF A THROTTLE IN HEMOLYSIS TESTS OF ROTARY BLOOD PUMPS

Affeld K, Lommel M, Rekus M, Thamsen B, Kertzscher U



27

12:00 O29

INCIDENCE AND RISK FACTOR OF GI BLEEDING AMONG PATIENTS SUPPORTED WITH CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE (CF-LVAD)

Miyamoto T, Nishinaka T, Umehara N, Ichihara Y, Tateishi M, Komagamine M, Katsube T, Saito S, Yamazak K

Cardiovascular surgery, Tokyo Womens Medical University, Tokyo, Japan

12:15 O30

INCIDENCE OF NON-SURGICAL BLEEDINGS DECREASES OVER TIME AFTER CONTINUOUS FLOW LVAD IMPLANTATION

Jacobs S, Rega F, Meyns B

Cardiac Surgery, KU Leuven, Leuven, Belgium

Special Symposium SP1 BIOART Initial Training Network: Training Network for Developing Innovative (Bio)artificial Devices for Treatment of Kidney and Liver Disease IL1-IL6

Lecture Hall B

Organizer & Chairman: Dimitrios STAMATIALIS, Twente, The Netherlands

11:00 IL1

Introduction of the BIOART Initial Training Network

Stamatialis D

Department of Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands

11:05 IL2

Novel membranes for blood puritification

Stamatialis D

Department of Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands

11:20 IL3

Microencapsulation of hepatic spheroids for bioartificial liver application

Legallais C

BMBI UMR 7338, Université de Technologie de Compiègne, Compiègne, France

11:35 IL4

The immunogenic response of conditionally immortalized renal proximal tubule epithelial cells for use in bioartificial kidney

Mihajlovic M

Utrecht University, Utrecht, The Netherlands

11:50 IL5

MASS AND MOMENTUM TRANSPORT IN PERFUSION BIOREACTORS FOR 3D LIVER CELL CULTURES: A MODELING APPROACH

Khakpour S

Institute on Membrane Technology, National Research Council of Italy,Rende, Italy

12:05 IL6

AN INNOVATIVE WAY OF USING PLURIPOTENT STEM CELLS AS SOURCE FOR FUNCTIONAL HUMAN HEPATOCYTE LIKE CELLS: FIRST STEP TOWARDS A LIVER MODEL

Strusi V

eXcorLab GmbH, Obernburg, Germany

12:20 QUESTIONS & ANSWERS – Plenary discussion with all speakers

Special Symposium SP2 Biodegradable Polymeric Scaffolds for Advanced Tissue Engineering Concepts KL1, IL7-IL9

Lecture Hall C

Organizer & Chairman: Nuno M. NEVES, Guimarães, Portugal

11:00 KL1

(O31)

FUNCTIONAL NANOFIBROUS SCAFFOLDS COMBINED WITH STEM CELLS FOR ADVANCED BIOMEDICAL DEVICES AND THERAPIES

Neves NM1,2

1 3B’s Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Guimarães, Portugal; 2 ICVS/3B’s, PT Government, Guimarães, Portugal

11:30 IL7 (O32)

BIO-INSPIRED INJECTABLE HYDROGELS AS IN SITU FORMING BIODEGRABLE SCAFFOLDS

Gallego-Ferrer G

Centre for Biomaterials and Tissue Engineering, Universitat Politecnica de Valencia, Valencia, Spain

11:50 IL8 (O33)

SILK FIBROIN-BASED HYDROGELS AS INSTRUCTIVE BIOLOGICAL MILIEU

Motta A1,2 1 Department of Industrial Engineering and BIOtech Research Centre, University of Trento, Trento, Italy; 2 European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Trento, Italy

12:10 IL9 (O34)

BIOMIMETIC SURFACE MODIFICATIONS FOR TISSUE ENGINEERING APPLICATIONS

Groth T, Koewitsch A, Zhao M, Yang Y, Esmaeilzadeh P

Biomedical Materials Group, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

Special Symposium SP3 Artificial Support of the Failing Liver: What’s Next? KL2, IL10-IL13

Lecture Hall D

Organizer & Chairman: Jacek ROZGA, Warsaw, Poland

11:00 KL2

LIVER SUPPORT WITH THE MARS SYSTEM – CURRENT STATUS

Mitzner S Department of Nephrology, University of Rostock, Rostock, Germany

11:30 IL10

HUMANIZED SPHEROID RESERVOIR BIOARTIFICIAL LIVER

Nyberg S

William J. von Liebeg Center for Transplantation and Clinical Regeneration, Mayo Clinic,Rochester, USA

11:50 IL11

SLOWING DOWN MULTIORGAN FAILURE COMBINED WITH ACCELERATION OF LIVER REGENERATION IS KEY TO LIVER SUPPORT

Stange J

Department of Internal Medicine, University of Rostock, Rostock, Germany


28

12:10 IL12

OPAL: A NEW OPTION FOR ALBUMIN DIALYSIS

Schmidt H

Department for Transplantation Medicine, University Hospital Münster, Münster,Germany

12:30 IL13

ALBUMIN APHERESIS – A NOVEL APPROACH TO BLOOD PURIFICATION AND TREATMENT OF SYSTEMIC INFLAMMATION

Rozga J

Department of Surgical and Transplantation Nursing, Warsaw Medical University, Warsaw, Poland

12:50 DISCUSSION

IFAO Meeting IF1-IF3

Lecture Hall A

Chairman: Bernd STEGMAYR, Umea, Sweden

13:15 IF1

DEVELOPMENT OF VARIOUS AUTOLOGOUS BIOPROSTHETIC GRAFTS WITH A UNIQUE IN-BODY TISSUE ENGINEERING

Takewa Y

National Cerebral and Cardiovascular Center, Osaka, Japan

13:30 IF2

WHY IS SURVIVAL ON HEMODIALYSIS DIFFERENT IN JAPAN, EUROPE AND USA? PLAUSIBLE OPTIONS

Stegmayr B

Internal Medicine, Div. Nephrology, Medicine Centre, University Hospital of Northern Sweden, Umea, Sweden

13:45 IF3

HEMODIALYSIS IN JAPAN

Matsuda K

University Yamanashi School of Medicine, Yamanashi, Japan

Kick-off Meeting of Bioartificial Organs ESAO Working Group

Lecture Hall B

Chairman: Dimitrios STAMATIALIS, Twente, The Netherlands

12:30 - 13:15 PROGRAM TBA DURING THE CONGRESS

Special Symposium SP4 10 years HeartWare HVAD: “What we Learned, What We Plan” Symposium sponsored by HeartWare IL14-IL17

Lecture Hall A

Chairmen: Heinrich SCHIMA, Vienna, Austria

14:00 IL14

HVAD - ITS ASSETS AND FURTHER ENHANCEMENTS

Brown M

HeartWare Inc, Miami, USA

14:20 IL15

CONTINUOUS NONINVASIVE MONITORING OF THE CARDIOVASCULAR PERFORMANCE IN DAILY ROUTINE AND EXERCISE

Moscato F

Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria

14:40 IL16

SURGICAL APPROACHES WITH THE HVAD PUMP

Zimpfer D

Department for Cardiothoracic Surgery, Medical University Vienna, Vienna, Austria

15:00 IL17

EXPERIENCE WITH CONTINUOS FLOW PUMPS AS A TREATMENT FOR END STAGE HEART FAILURE PATIENTS

Pacholewicz J

Silesian Center for Heart Diseases, Zabrze, Poland

15:20 DISCUSSION

Special Symposium SP5 Larger Uremic Toxins: Clinical Relevance and Dialytic Strategies for Removal, KL3, IL18-IL20

Lecture Hall B

Organizer & Chairman: Bengt LINDHOLM, Stockholm, Sweden

14:00 KL3

TARGETING LARGE UREMIC TOXINS

Eloot S Nephrology, Ghent University Hospital, Ghent, Belgium

14:30 IL18

HIGH CUT OFF MEMBRANES FOR HEMODIALYSIS

Girndt M

Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Halle, Germany

14:45 IL19

LARGE SOLUTE REMOVAL WITH HEMODIAFILTRATION AND HEMOFILTRATION

Argiles A

RD - Néphrologie, Montpellier, France

15:00 IL20

REMOVAL OF LARGE SOLUTES BY PERITONEAL DIALYSIS

Waniewski J

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland

15:15 DISCUSSION

Special Symposium SP6 Biomimetic Devices for Tissue and Organ Regeneration Symposium Co-sponsored by the Internatinal Centre of Biocybernetics KL4, IL21, IL22, O38, O39

Lecture Hall C

Organizers & Chairmen: João F. MANO, Aveiro, Portugal, Thomas GROTH, Halle, Germany

14:00 KL4

(O35)

OPEN AND CLOSED POLYMERIC THREE-DIMENSIONAL STRUCTURES FOR TISSUE ENGINEERING

Mano JF Department of Chemistry. CICECO, University of Aveiro, Aveiro, Portugal


29

14:25 IL21 (O36)

LIVING BIOINTERFACES BASED ON NON-PATHOGENIC BACTERIA TO HARNESS STEM CELL BEHAVIOUR

Salmeron-Sanchez M

Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow, UK

Presentations IL21 (O36) and O39 will be delivered as one lecture by Dr. Marco Cantini from Biomedical Engineering Research Division School of Engineering, University of Glasgow.

14:40 O39

MATERIAL-DRIVEN FIBRONECTIN NANONETWORKS PROMOTE MAINTENANCE OF MESENCHYMAL STEM CELL PHENOTYPES

Rico P1, Mnatsakanyan H2, Salmerón-Sánchez M3 1 Centre for Biomaterials and Tissue Engineering, Universidad Politecnica de Valencia. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Valencia, Spain; 2 Centre for Biomaterials and Tissue Engineering, Universitat Politècnica de València, Valencia, Spain; 3 Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow, UK

14:55 IL22 (O37)

FAST-DEGRADATION HYDROPHILIC-HYDROPHOBIC ENVIRONMENTS FOR CELL TRANSPLANTATION

Gámiz-González MA1, Guldris P1, Antolinos Turpín CM2, Ródenas Rochina J1, Vidaurrea A2, Gómez Ribelles JL1

1 Center for Biomaterials and Tissue Engineering (CBIT), Universitat Politècnica de València, Cno. de Vera s/n, 46022, Valencia, Spain; 2 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valencia, Spain

15:15 O38

ENHANCEMENT OF ENDOTHELIAL CELL ADHESION ON EPTFE SUBSTRATE BY THE IMMOBILIZATION OF FIBRONECTIN-DERIVED PEPTIDE VIA SINGLE-STEP TYR OXIDATION

Kakinoki S1, Suzuki S1, Nishioka S1, Yamaoka T2, Hirano Y1 1 Faculty of Chemistry, Materials and Bioengineering, Department of Chemistry and Materials Engineering, Kansai University, Osaka, Japan; 2 Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

Special Symposium SP7 ALBUMIN - an Old Molecule with New Insights IL23-IL26

Lecture Hall D

Organizers and Chairmen: Ulrich BAURMEISTER, Wuppertal, Jörg VIENKEN, Usingen, Germany

14:00 IL23 (O40)

PROPERTIES AND ANALYSIS OF FUNCTIONAL CHARACTERISTICS OF HUMAN SERUM ALBUMIN

Schnurr K, Waterstradt K

MedInnovation GmbH, Berlin, Germany

14:20 IL24 (O41)

MEASURING DEVICE FOR THE NON-INVASIVE DETERMINATION OF BILIRUBIN DURING EXTRACORPOREAL LIVER SUPPORT THERAPY

Preussiger M1, Tyczynski B2, Kribben A2, Jost U3, Jungmann H1 1 MBR Optical Systems GmbH & Co. KG, Wuppertal, Germany; 2 Universität Duisburg-Essen, Wuppertal, Klinik für Nephrologie, Essen, Germany; 3 HepaNet GmbH, Hannover, Germany

14:40 IL25 (O42)

THE ALBUMIN BINDING CAPACITY (ABIC): BIOMARKER OR THERAPEUTIC TARGET?

Mitzner S1,2, Stange J1, Klammt S2,3 1 Division of Nephrology, Department of Medicine, University of Rostock, Rostock, Germany; 2 Fraunhofer Project Group EXIM, Rostock, Germany; 3 Charité Research Organisation (CRO), Berlin, Germany

15:00 IL26 (O43)

ALBUMIN IS HERE TO STAY...OR TO BE REMOVED: STILL OPEN QUESTIONS

Vienken J1, Baurmeister U2 1 Usingen, Germany; 2 Wuppertal, Germany

15:20 DISCUSSION

Oral Session OS6 Cardiovascular Implants for Children O44-O48

Lecture Hall A

Chairmen: Bart MEYNS, Leuven, Belgium, Daniel ZIMPFER, Vienna, Austria

16:30 O44

THE NEW POLISH PEDIATRIC VAD FAMILY DEVELOPMENT AND PRE-CLINICAL STUDIES

Kustosz R1, Gonsior M1, Ścigała P2, Czingon M3, Kapis A1, Pacholewicz J4, Kubacki K4, Gawlikowski M1, Bujok W1, Głowacki M1, Janiczak K1, Cieśla P1, Zawidlak-Węgrzyńska B1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Clinic for Animals Piotr Ścigała, Piekary Slaskie, Poland; 3 Clinic for Animals Michał Czingon, Zabrze, Poland; 4 Silesian Center for Heart Diseases, Zabrze, Poland

16:45 O45

A NOVEL TEST BENCH TO SIMULATE THE INTERACTION OF VAD WITH THE FAILING SUPERIOR CAVO-PULMONARY CONNECTION

De Gaetano F1, Griselli M2, Soos P3, Costantino M1 1 Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milano, Italy; 2 Department of Cardiac Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; 3 Berlin Heart GmbH, Berlin, Germany

17:00 O46

OFF-LABEL USE OF STRETCHABLE POLYTETRAFLUOROETHYLENE: OVEREXPANSION OF SYNTHETIC SHUNTS

Verbelen T1, Famaey N2, Gewillig M3, Rega F1, Meyns B1 1 Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium; 2 Mechanical Engineering, KU Leuven, Leuven, Belgium; 3 Pediatric Cardiology, University Hospitals Leuven, Leuven, Belgium

17:15 O47

OBSTRUCTED MECHANICAL VALVE IN MITRAL POSITION IN SMALL CHILDREN : PROSTHETIC MANAGEMENT STRATEGIES

Chan-Dominy A1, Krupickova S2, Ghez O3, Michielon G3, Burmester M1, Casanueva L1, Fraisse A2 1 Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK; 2 Paediatric Cardiology, Royal Brompton & Harefield NHS Foundation Trust, London, UK; 3 Paediatric and Congenital Heart Surgery, Royal Brompton & Harefield NHS Foundation Trust, London, UK


30

17:30 O48

TREND OF ECHOCARDIOGRAPHIC AND ENERGETIC PARAMETERS IN LVAD PEDIATRIC PATIENTS

Di Molfetta A1, Iacobelli R2, Ferrari G3, Filippelli S1, Trivella M4, Amodeo A1 1 Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 2 Medical and Surgical Department of Pediatric Cardiology, Pediatric Hospital Bambino Gesu, Rome, Italy; 3 Section of Rome, Cardiovascular engineering, CNR - Institute of clinical Physiology, Rome, Italy; 4 CNR - Institute of Clinical Physiology, Pisa, Italy

Oral Session OS7 Clinical Aspects of Hemodialysis O49-O54

Lecture Hall B

Chairmen: Sunny ELOOT, Gent, Belgium, Jacek WANIEWSKI, Warsaw, Poland

16:30 O49

CARDIAC FUNCTION AND SOME OTHER RISK FACTORS RELATED TO VITAMIN D DEFICIENCY IN PATIENTS WITH CHRONIC RENAL FAILURE(CRF) ON HEMODIALYSIS (HD)

Yonova D, Georgiev M, Antonov S

Medical Faculty, Medical University, Sofia, University Dialysis Center, Sofia, Bulgaria

16:45 O50

CHANGES IN PULSE WAVE THROUGHOUT HEMODIALYSIS SESSION

Dębowska M1, Wójcik-Załuska A2, Dąbrowski W3, Poleszczuk J1, Książek A4, Załuska W4, Waniewski J1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Department of Physical Therapy and Rehabilitation, Medical University of Lublin, Lublin, Poland; 3 Department of Anesthesiology and Intensive Therapy, Medical University of Lublin, Lublin, Poland; 4 Department of Nephrology, Medical University of Lublin, Lublin, Poland

17:00 O51

INFLUENCE OF CLINICAL PARAMETER VARIATION ON IDH ONSET DURING THE FIRST MINUTES OF THE HD TREATMENT

Vito D, Casagrande G, Bianchi C, Costantino M

Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milano, Italy

17:15 O52

CORRELATES OF CIRCULATING INTERFERON-λ3 (IFN-λ3) IN HEMODIALYSIS (HD) PATIENTS

Grzegorzewska A1, Świderska M2, Warchoł W3 1 Department of Nephrology, Transplantology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland; 2 Student Nephrology Research Group, Poznan University of Medical Sciences, Poznan, Poland; 3 Department of Biophysics, Poznan University of Medical Sciences, Poznan, Poland

17:30 O53

CARDIOPULMONARY BYPASS: ASSESSING THE RISK OF RENAL INJURY.

Abbasciano R, Mancini A, San Biagio L, Lucarelli C, Franzese I, Piani D, Onorati F, Tessari M, Menon T, Faggian G

Department of Cardiac Surgery, University of Verona, Verona, Italy

17:45 O54

GLUCOSE-FREE DIALYSATE REDUCED SKIN AUTOFLUORESCENCE AS A MARKER FOR CARDIOVASCULAR DISEASES

Stegmayr B1, Ramsauer B1, Engels G2, Graaff R3, Sikole A4, Arsov S5, Hadimeri H6 1 Public Health and Clinical Medicine, Umea University, Umea, Sweden; 2 Groningen, Haemoscan BV, Groningen, The Netherlands; 3 UMC Staff and Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen,nd the Netherland, Groningen, The Netherlands; 4 University Sts Cyril and Methodius, Hospital of Nephrology, Skopje, The Former Yugoslav Republic of Macedonia; 5 Skopje, PZU Diamed-Makedonija, Skopje, The Former Yugoslav Republic of Macedonia; 6 Nephrology, Skaraborgs Hospital, Skövde, Sweden

Oral Session OS8 Mechanisms of Blood Trauma O55-O59

Lecture Hall C

Chairmen: Ulrich KERTZSCHER, Berlin, Germany, Simon J. SONNTAG, Aachen, Germany

16:30 O55

ON THE SIGNIFICANCE OF EXPOSURE TIME IN COMPUTATIONAL BLOOD DAMAGE ESTIMATION

Pauli L, Haßler S, Behr M

Chair for Computational Analysis of Technical Systems, RWTH Aachen University, Aachen, Germany

16:45 O56

THE IMPACT OF ARTIFICIAL SHEAR STRESS ON LEUKOCYTES AT A BIOMATERIAL INTERFACE

Radley G1, Pieper I2, Chan C2, Moriarty C2, Foster G2, Hawkins K1, Thornton C1 1 Medical School, Swansea University, Swansea, UK; 2 Calon Cardio-Technology Ltd, Swansea, UK

17:00 O57

ENERGY DISSIPATION RATE AS ALTERNATIVE HEMOLYSIS METRIC IN STRESS-BASED MODELS

Engel S, Janiga G, Thévenin D

Laboratory of Fluid Dynamics & Technical Flows, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany

17:15 O58

COMPARISON OF HEAT TRANSFER DYNAMICS IN A MODEL OF THE ARTERIAL SYSTEM DURING CONTINUOUS OR PULSATILE EXTRACORPOREAL CIRCULATION

Casagrande G, Costantino M


17:30 O59 LONG TERM EVALUATION OF A NOVEL VERSATILE BIOPROSTHETIC VALVE MADE BY AUTOLOGOUS TISSUES

Takewa Y1, Nakayama Y2, Sumikura H1, Iizuka K1, Katagiri N1, Takeshita D1, Tatsumi E1 1 Department of Artificial Organs, National Cerebral and Cardiovascular Center, Osaka, Japan; 2 Medical Engineering and Materials, National Cerebral and Cardiovascular Center, Osaka, Japan


31

Oral Session OS9 Cells and Polymers for Tissue Engineering O60-O64

Lecture Hall D

Chairmen: Dorota G. PIJANOWSKA, Warsaw, Poland, Pedro M. BAPTISTA, Zaragoza, Spain

16:30 O60

A NOVEL PERFUSION BIOREACTOR FOR MAMMALIAN CELL CULTURE

Wawro B, Kruk J, Dudziński K, Kazimierczak B, Zakrzewska K, Samluk A, Kowalska A, Pijanowska D, Torbicz W


16:45 O61

ESTABLISHMENT AND CHARACTERIZATION OF HUMAN RENAL PRIMARY CULTURES TO USE IN MICROFLUIDIC DEVICES

Sánchez-Romero N, Giménez I

Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain

17:00 O62

FIBRIN GEL AS NATURAL SCAFFOLD FOR HUMAN STEM CELLS (WJ-MSC AND HIPSC-NPS) IN NEURODEGENERATIVE DISEASES TREATMENT

Zychowicz M, Figiel- Dąbrowska A, Lech W, Obtułowicz P, Winiarska H, Domańska-Janik K, Bużańska L

Stem Cell Bioengineering Unit, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland

17:15 O63

USE OF DECELLULARIZED TRACHEAS FOR AIRWAY ENGINEERING

Sancho-Tello M1, Milián L1, Carda C1, Garzón I2, Foschinni G3, Galán G3, Mata M4 1 Departamento Patología, Universidad de Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain; 2 Histology department, Universidad de Granada, Granada, Spain; 3 Thoracic Surgery Unit, Hospital Clínico Universitario de Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain; 4 Departamento Patología, Universidad de Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital Clínico Universitario de Valencia; Centro de Investigaciones en Red de Enfermedades Respiratorias (CIBERES), Valencia, Spain

17:30 O64

POLYMERS WITH MICRO- AND NANOSTRUCTURED SURFACE FOR IMPLANTS AND FOR TISSUE ENGINEERING

Thormann A1, Rudolph M2, Heilmann A1 1 Biological and Macromolecular Materials, Fraunhofer IMWS, Halle, Germany; 2 Electrotechnics and Maschine Builiding, Anhalt University of Applied Sciences, Bernburg, Germany

Plenary Lectures, Special Symposia and Oral Sessions Friday, September 16th

32

FRIDAY, September 16th

Oral Session OS10 From Bench to Bedside O65-O70

Lecture Hall A

Chairmen: Maria Giovanna TRIVELLA, Rome, Italy, Klaus AFFELD, Berlin, Germany

8:30 O65

THE INNOVATIVE MATERIAL TECHNOLOGIES APPLICATION FOR THE IMPLANTABLE ROTARY BLOOD PUMP RELIGA HEART® ROT

Gonsior M1, Darłak M1, Altyntsev I1, Wierzchoń T2, Antonowicz M1, Kustosz R1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland

8:45 O66

THE ABILITY OF REMOTELY MONITORING THE OPERATION OF PULSATILE VENTRICULAR ASSIST DEVICE ON THE EXAMPLE OF SET: RH PED – DUO CONTROLLER

Czak M, Gawlikowski M, Kustosz R

Artificial Heart Labolatory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland

9:00 O67

INFLUENCE OF AORTIC VALVE REGURGITATION UNDER LVAD SUPPORT ON HEMODYNAMICS AND CARDIAC METABOLISM IN ACUTE ANIMAL EXPERIMENTS

Iizuka K, Naito N, Sumikura H, Mizuno T, Tsukiya T, Takewa Y, Tatsumi E

Department of Artificial Organs, National Cerebral and Cardiovascular Center, Osaka, Japan

9:15 O68

SINGLE PULMONARY ARTERY SUPPORT FOR THE FAILING FONTAN CIRCULATION IN SHEEP

Van Puyvelde J1, Rega F1, Nix C2, Hazekamp M3, Rijnberg F3, Siess T2, Claus P4, Cools B5, Gewillig M5, Meyns B1 1 Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium; 2 Abiomed Europe GmbH, Aachen, Germany; 3 Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands; 4 Department of Cardiovascular Imaging and Dynamics, University Hospitals Leuven, Leuven, Belgium; 5 Department of Paediatric Cardiology, University Hospitals Leuven, Leuven, Belgium

9:30 O69

POSTOPERATIVE LEFT VENTRICULAR FUNCTION IN DIFFERENT TYPES OF PULMONARY HYPERTENSION: A COMPARATIVE STUDY

Verbelen T1, Van De Bruaene A2, Cools B3, Van Raemdonck D4, Delcroix M5, Rega F1, Meyns B1 1 Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium; 2 Cardiology, University Hospitals Leuven, Leuven, Belgium; 3 Pediatric Cardiology, University Hospitals Leuven, Leuven, Belgium; 4 Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium; 5 Pneumology, University Hospitals Leuven, Leuven, Belgium

9:45 O70

HIGH-DOSE ADENOSINE-LIDOCAINE-MAGNESIUM POLARIZED ARREST IN ELECTIVE CARIDAC SURGERY: RESULTS OF THE FIRST HUMAN RANDOMIZED CONTROLLED TRIAL

Abbasciano R1, Onorati F1, San Biagio L1, Lucarelli C1, Fanti D1, Dobson G2, Menon T1, Gottin L3, Biancari F4, Tessari M1, Mazzucco A1, Faggian G1 1 Department of Cardiac Surgery, University of Verona, Verona, Italy; 2 College of Medicine and Dentistry, Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Townsville, Australia; 3 Division of Cardiac Surgery and Postoperative Intensive Care Unit, University of Verona, Verona, Italy; 4 Division of Cardiac Surgery, University of Oulu, Oulu, Finland

Oral Session OS11 Adsorption and Uremic Toxins O71-O76

Lecture Hall B

Chairmen: Asma ALLAL, Toulouse, France, Angel ARGILES, Montpellier, France

8:30 O71

POLYETHERSULFONE AND SLIPSKIN BLEND MEMBRANES FOR DIALYSIS TREATMENT

ter Beek O, Pavlenko D, Suck M, Stamatialis D

Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands

8:45 O72

CONFORMATION AND DYNAMICS AT A MESOSCOPIC LEVEL OF BIOMACROMOLECULES ADSOPTION: A COARSE-GRAINED MOLECULAR SIMULATION

Sabater i Serra R1, Constantino T2, José María M1, Gómez Ribelles J1, Molina-Mateo J2 1 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Universitat Politècnica de València/Centre for Biomaterials and Tissue Engineering, Valencia, Spain; 2 Centre for Biomaterials and Tissue Engineering, Universitat Politècnica de València, Valencia, Spain

9:00 O73

STRATEGIES FOR DIALYSATE REGENERATION USING MIXED MATRIX MEMBRANES

Geremia I, Stamatialis D

Department of Biomaterials Science and Technology - Faculty, University of Twente, Enschede, The Netherlands

9:15 O74

SUCCESSFUL TRANSPLANTATION IN ABO- AND HLA-INCOMPATIBLE LIVING KIDNEY-TRANSPLANT PATIENTS: A REPORT ON 12 CASES

Rostaing L1, Karam B2, Congy-Jolivet N3, Hage V2, Sallusto F4, Esposito L2, Doumerc N4, Debiol B5, Guilbeau-Frugier C6, Game X4, Allal A2, Kamar N2 1 Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; 2 Department of Nephrology and Organ Transplantation, CHU Toulouse Rangueil, Toulouse, France; 3 Department of Immunology, CHU Toulouse Rangueil, Toulouse, France; 4 Department of Urology and Organ Transplantation, CHU Toulouse Rangueil, Toulouse, France; 5 Etablissement Français du Sang, CHU Toulouse Purpan, Toulouse, France; 6 Service d'Anatomie et Cytologie Pathologiques, CHU Toulouse Rangueil, Toulouse, France


33

9:30 O75

SPERMATOZOA INITIALLY INCREASE MOTILITY AS TO ESCAPE UREMIC TOXIN ENVIRONMENT

Vollmer T1, Glorieux G2, Jankowski V3, Jankowski J3, Stegmayr B1 1 Internal Medicine, Div. Nephrology, Medicine centre, University Hospital of northern Sweden, Umea, Sweden; 2 Nephrology Section, Department of Internal Medicine, University of Ghent, Ghent, Belgium; 3 Institute for Cardiovascular Research, RWTH Aachen University, Aachen, Germany,

9:45 O76

ESTIMATED GFR POORLY REFLECTS CONCENTRATIONS OF VARIOUS URAEMIC TOXINS IN PAEDIATRIC CKD PATIENTS: NEW TOOLS ARE NEEDED TO IMPROVE DIAGNOSIS

Snauwaert E1, Van Biesen W2, Raes A1, Vande Walle J1, Eloot S2 1 Paediatric Nephrology, Ghent University Hospital, Ghent, Belgium; 2 Nephrology, Ghent University Hospital, Ghent, Belgium

Oral Session OS12 Implants and Scaffolds O77-O81

Lecture Hall C

Chairmen: Ludomira GRANICKA, Warsaw, Poland, Andreas HEILMANN, Halle, Germany

8:30 O77

ELECTROSPUN COLLAGEN NANOFLEECES FOR APPLICATIONS IN THE FIELD OF REGENERATIVE MEDICINE

Milosevic J1, Kürbitz T2, Heine C1, Hasan S1, Herbst C1, Meisel H1, Heilmann A3 1 SpinPlant GmbH Leipzig, Leipzig, Germany; 2 Electrotechnics and Maschine Builiding, Anhalt University of Applied Sciences, Bernburg, Germany; 3 Biological and Macromolecular Materials, Fraunhofer IMWS, Halle, Germany

8:45 O78

3D NANOMATERIALS FOR REGENERATION OF CONNECTIVE TISSUE, SUCH AS CARTILAGE

Gerasimenko A1, Podgaetsky V1, Ichkitidze L1, Telyshev D1, Eganova E2, Pavlov A2, Selyshchev S1 1 Biomedical systems, National Research University of Electronic Technology, Moscow, Russian Federation; 2 Department of development and research of micro and nanosystems, Institute of Nanotechnology of Microelectronics of the Russian Academy of Sciences, Moscow, Russian Federation

9:00 O79

DEVELOPMENT OF BIODEGRADABLE INJECTABLE SYSTEM BASED ON CHITOSAN AND CALCIUM PHOSPHATE

Rogina A1, Matic I2, Ressler A1, Gallego Ferrer G3, Ivankovic M1, Ivankovic H1 1 Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia; 2 Faculty of Science, University of Zagreb, Zagreb, Croatia; 3 Center for Biomaterials and Tissue Engineering (CBIT), Universitat Politècnica de València, València, Spain

9:15 O80

BIOCOMATIBILITY STUDY OF AN INNOVATIVE ELASTOMER FOR LONG TERM IMPLANTS APPLICATION

Zawidlak-Węgrzyńska B1, Ścigała P2, Gonsior M1, Janiczak K1, Gawlikowski M1, Cieśla P1, Kustosz R1, El Fray M3, Piegat A3 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Emergency and Specialty Animal Medical Center, Piekary Slaskie, Poland; 3 Polymer Institute, Biomaterials and Microbiology Technologies Dept., West Pomerania University of Technology, Szczecin, Poland

9:30 O81

IN VITRO CALCIFICATION: ADVANCING THROUGH THE DEVELOPMENT OF AN ACCURATE MODEL

D'Alessandro C1, Badria A1, Ratna Tuladhar S2, Gerosa G2, Korossis S3, Koutsoukos P4, Mavrilas D1 1 Mechanical and Aeronautical, University of Patras, Patras, Greece; 2 Cardiac Thoracic and Vascular Sciences, Universitá degli Studi Padova, Padova, Italy; 3 Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany; 4 Chemical Engineering, University of Patras, Patras, Greece

Oral Session OS13 Modelling in silico and in vivo O82-O87

Lecture Hall D

Chairmen: Gianfranco FERRARI, Rome, Italy Tim A.S. KAUFMANN, Aachen, Germany

8:30 O82

IMPACT OF ROTARY BLOOD PUMP SPEED STEPS ON INTRAVENTRICULAR FLOW PATTERNS

Aigner P, Moscato F, Schima H

Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Ludwig Boltzmann Gesellschaft, Vienna, Austria

8:45 O83

IMAGE BASED FITTING OF NEW INFLOW CANNULA FOR THE EVAHEART LVAS

Sonntag S1, Neidlin M1, Groß-Hardt S2, Benkowski R3, Motomura T4, Steinseifer U2, Kaufmann T2 1 enmodes GmbH, Aachen, Germany; 2 Department of Cardiovascular Engineering, RWTH Aachen, Institute of Applied Medical Engineering, Aachen, Germany; 3 B-Squared Medical Device Solutions LLC, Fort Worth, USA; 4 Evaheart Medical USA Inc, Houston, USA

9:00 O84

INFLUENCE OF LVAD INFLOW CANNULA POSITIONING ON VENTRICULAR HEMODYNAMICS WITH A FLUID-STRUCTURE INTERACTION MODEL

Neidlin M1, Sonntag S1, Groß-Hardt S2, Steinseifer U2, Kaufmann T2 1 enmodes GmbH, Aachen, Germany; 2 Department of Cardiovascular Engineering, RWTH Aachen University, Institute of Applied Medical Engineering, Aachen, Germany

9:15 O85

HEMODYNAMIC CHANGES IN RESPONSE TO IMPROVED VENTRICULAR CON-TRACTILITY DURING CONTINUOUS FLOW LVAD SUPPORT: IN-VITRO STUDY

Suciu AM, Khir AW

Brunel Institute for Bioengineering, Brunel University London, Uxbridge, UK


34

9:30 O86

A COMPUTER MODEL OF A HEART MUSCLE - CORONARY SYSTEM INTERACTION FOR IABP ASSISTANCE HYBRID SIMULATIONS

Zieliński K1, Kozarski M1, Górczyńska K1, Ferrari G2, Darowski M1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Section of Rome, Cardiovascular Engineering, CNR - Institute of Clinical Physiology, Italy

9:45 O87

IN-VITRO TESTS RESULTS PROVIDE NEW INSIGHT INTO PROSTHESIS BEHAVIOR: A HELP FOR CLINICIANS TO CHOOSE PROSTHESIS AND SIZE IN AORTIC VALVE REPLACEMENT

Egron S1, Fujita B2, Ensminger S2, Doose C1, Pott D1, Steinseifer U1 1 Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, Germany; 2 Department for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany

Plenary Lecture 3

Lecture Hall A

Chairman: Thomas GROTH, Halle, Germany

10:10 PL3 NEW STRATEGIES FOR THE ENGINEERING OF DIFFERENT HUMAN TISSUES

Rui L. Reis 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, Guimarães, Braga, Portugal

Special Symposium SP8.1 ICCAC VAD Coordinator Symposium (Session 1) IL27-IL31

Lecture Hall A

Moderators: Tonya ELLIOTT, Washington DC, USA, Thomas SCHLÖGLHOFER, Vienna, Austria

11:00 IL27

FROM BENCH TO BEDSIDE

Kustosz R

Artificial Heart Laboratory, Zbigniew Religa Foundation of Cardiac Surgery Development, Zabrze, Poland

11:20 IL28

HEARTMATE- III: BLACK BOX / BRIGHT FUTURE?

Kaufmann F

Department of Cardiothoracic and Vascular Surgery, German Heart Institute, Berlin, Germany

11:40 IL29

A COMPARISON OF INR TIME IN RANGE PRE AND POST INITIATION OF A STANDARDIZED PROTOCOL

Thompson M

University of Minnesota Medical Center, Minneapolis, USA

12:00 IL30

USE OF SMALL GROUP PROBLEM BASED LEARNING SCENARIOS AS A METHOD FOR ADVANCED MCS THERAPY CONTINUING EDUCATION REQUIREMENTS AND CERTIFICATION

Christensen D

Innovative Program Solutions LLC, Pennsylvania, USA

12:15 IL31

PEDIATRIC MECHANICAL CIRCULATORY SUPPORT - CHALLENGES AND OPPORTUNITIES

Horvat J

Medical University of Vienna, Vienna, Austria

Special Symposium SP9 Changing Perspectives in Extracorporeal Treatment: from Passive Dialysis Removal to Active Interaction on the Biology of the Patient IL32-IL36

Lecture Hall B

Organizer & Chairman: Andrea BUSCAROLI, Ravenna, Italy

11:00 IL32

DOES IT STILL MAKE SENSE TO DEVELOP NEW MEMBRANES AND HEMODIALYSERS OR CANNOT WE GO ANY FURTHER?

Catapano G

Department of Environmental and Chemical Engineering, University of Calabria, Rende, Italy

11:15 IL33

CREATING A FUNCTIONAL BIOARTIFICIAL TUBULE

Stamatialis D

Department of Biomaterials Science and Technology, University of Twente, Enchede, The Netherlands

11:30 IL34

THE ROLE OF THE SORPTION IN THE EXTRACORPOREAL TREATMENT: ONLY TOXINS OR IS THERE MORE?

Mikhalovsky S

School of Pharmacy and Environmental Chemistry, University of Brighton, Brighton, UK

11:45 IL35

MEDIUM CUT-OFF MEMBRANES - CLOSER TO THE NATURAL KIDNEY REMOVAL FUNCTION

Krause B

Gambro Dialysatoren GmbH, Hechingen, Germany

12:00 IL36

THE CLINICAL EXPECTATIONS FROM THE NEW BIOACTIVE TREATMENTS: GREATER WELL-BEING OR LONGER SURVIVAL?

Argiles A


12:15 DISCUSSION


35

Special Symposium SP10 Implantable Biosensors KL5, IL37-IL39

Lecture Hall C

Organizer & Chairman: Erik A. JOHANNESSEN, Borre, Norway

11:00 KL5

(O88)

CONTINUOUS GLUCOSE MONITORING IN HUMANS USING A LONG-TERM IMPLANTED SENSOR/TELEMETRY SYSTEM

Gough DA1, Routh TL2, Lin JT2, Lucisano JY2

1 Department of Bioengineering, University of California, CA 92093, San Diego, La Jolla, USA; 2 GlySens Incorporated, 3931 Sorrento Blvd., Suite 110, CA 92121, San Diego, USA

11:30 IL37 (O89)

MONITORING OXYGEN WITH OPTICAL SENSORS IN CELL CULTURE, ARTIFICIAL AND NATIVE TISSUE

Meier R, Liebsch G

PreSens Precision Sensing, Regensburg, Germany

11:45 IL38 (O90)

IMPROVED PLATINUM ANODES FOR THE OPERATION OF IMPLANTABLE GLUCOSE FUEL CELLS IN REAL PHYSIOLOGICAL FLUIDS

Frei M, Bühler M, Erben J, Kerzenmacher S

IMTEK - Department of Microsystems Engineering, University of Freiburg, Freiburg, Germany

12:00 IL39 (O91)

ADVANCES IN NANOTECHNOLOGY FOR ORGAN REPLACEMENT: A SUMMARY OF 15 YEARS OF RESEARCH AND COMMERCIALIZATION

Webster TJ

Department of Chemical Engineering, Northeastern University, Boston, USA

Special Symposium SP11 Liver Decellularization: a Second Life for Liver Bioengineering, Bioartificial Livers and Extracorporeal Liver Perfusion Machines KL6, IL40-IL44

Lecture Hall D

Chairmen: Juan F. Del CAÑIZO, Madrid, Spain, Pedro M. BAPTISTA, Zaragoza, Spain

11:00 KL6

LIVER TISSUE ENGINEERING IN VITRO AND IN VIVO

Soto-Gutierrez A Department of Pathology, University of Pittsburgh, Pittsburgh, USA

11:30 IL40

MICROENCAPSULATED HEPATOCYTES AND BIOARTIFICIAL LIVER : IS HERE A PLACE FOR EXTRACELLULAR MATRIX?

Legallais C

Université de Technologie de Compiègne, Compiègne, France

11:45 IL41

THE CLINICAL DEVELOPMENT OF A BIOARTIFICIAL LIVER: THE ELAD EXPERIENCE

Ashley R

Vital Therapies, Inc, San Diego, USA

12:00 IL42 (O92)

EXTRACORPOREAL LIVER PERFUSION MACHINES: THE GOOD, THE BAD AND... THE FEASIBLE?

Sanchez Del Arco R, Gutierrez-Gutierrez J, Del Cañizo J

Department of Surgery. Universidad Complutense de Madrid, Laboratorio de Circulacion Artificial. Hospital General Universitario Gregorio Maranon, Madrid, Spain

12:15 IL43

THE NEW EX-VIVO WORLD: MACHINE PERFUSION WITH A NEW HEMOGLOBIN BASED OXYGEN CARRIER SOLUTION

Fontes P

Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, USA

12:30 IL44 (O93)

LIVER DECELLULARIZATION: A SECOND LIFE FOR LIVER BIOENGINEERING, BIOARTIFICIAL LIVERS AND EXTRACORPOREAL LIVER PERFUSION MACHINES

Baptista P1, Del Cañizo J2 1 Instituto de Investigacion Sanitaria de Aragon, Saragossa, Spain; 2 Cirugia Experimental, Hospital Universitario Gregorio Marañon, Madrid, Spain

ESAO Corporate Members Symposium Beyond Tissue Engeneering - Technical Organ Replacement Is Still Saving Lives CM1-CM3

Lecture Hall A

Chairman: Ares K. Menon, Berlin, Germany

13:00 CM1

BIOCOMPATIBILITY & DIALYZERS: WHAT’S NEXT?

Gebert M

Research & Development, Gambro Dialysatoren GmbH, Hechingen , Germany

13:15 CM2

VADs AFTER MORE THAN 15 YEARS OF CLINICAL EXPERIENCE – WHERE ARE THE LIMITS?

Granegger M

Research & Development, Berlin Heart GmbH, Berlin, Germany

13:30 CM3

TECHNICAL ADVANCEMENTS: SAVING LIVES VERSUS WILLINGNESS TO PAY

Busink E

Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany

Special Symposium SP8.2 ICCAC VAD Coordinator Symposium (Session 2) IL45-IL48

Lecture Hall A

Moderators: Maureen THOMPSON, Minneapolis, USA, Roman KUSTOSZ, Zabrze, Poland

14:00 IL45

VAD COORDINATOR PERSPECTIVE: CHARACTERISTICS OF A SUCCESSFUL MCS PROGRAM

Elliott T

MedStar Washington Hospital Center, Washington DC, USA


36

14:30 IL46

REMEDIZER -MONITORING SYSTEM FOR PATIENTS WITH MCS

Szymanski J

Institute of Cardiology, Warsaw, Poland

14:50 IL47

SWITCH FROM SHORT-TERM TO LONG-TERM MECHANICAL CIRCULATORY SUPPORT AS A BRIDGE TO HEART TRANSPLANTATION

Halbe M

Clinic of Cardiac and Vascular Surgery, University Hospital Zurich, Zurich, Switzerland

15:10 IL48

NON- THERMAL PLASMA APPLICATION FOR VAD DRIVELINE MANAGEMENT

Bach R

Schuechtermann-Schiller Clinic, Bad Rothenfelde, Germany

Special Symposium WG1 Apheresis Working Group Symposium IL49-IL56

Lecture Hall B

Chairmen: Horst KLINKMANN, Rostock, Germany Volker WITT, Vienna, Austria

13:30 IL49

OVERVIEW OF MAIN INDICATIONS FOR APHERESIS. WAA DATA

Stegmayr B


13:40 IL50

OVERVIEW OF APHERESIS TECHNIQUES USED IN CLINICAL PRACTISE. WAA DATA

Stegmayr B


13:50 IL51

GERMAN LIPID APHERESIS REGISTRY AND DATA

Schettler V

Center of Nephrology Goettingen GbR, Göttingen, Germany

14:10 IL52

TREATMENT OF SEPSIS BY VARIOUS DEVICES FOR ADSORPTION TECHNOLOGY

Mitzner S

Department of Medicine, Division of Nephrology, University of Rostock, Rostock, Germany

14:30 IL53

GRANULOCYTE TRANSFUSIONS IN SEVERE SEPSIS

Witt V

Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Vienna, Austria

14:45 IL54

GRANULOCYTE BASED BIOREACTOR TREATMENT OF SEPSIS

Mitzner S

Department of Medicine, Division of Nephrology, University of Rostock, Rostock, Germany

14:55 IL55

MARGINAL GROUPS FOR APHERESIS. WAA DATA

Witt V

Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Vienna, Austria

15:10 IL56

IGE APHERESIS. A NEW INDICATION FOR ACUTE ALLERGIC REACTIONS

Valenta R

Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria

Special Symposium S12 Extracellular Vesicles: Markers of Cellular Activation and Contributors to Coagulation and Inflammation Symposium in memory of Prof. Dieter Falkenhagen KL7, IL57-IL59

Lecture Hall C

Organizer & Chairman: Viktoria WEBER, Krems, Austria

14:00 KL7

RECENT LESSONS OF EXTRACELLULAR VESICLE ISOLATION FROM PERIPHERAL BLOOD SAMPLES

Buzas E Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary

14:30 IL57

HOW TO MEASURE EXTRACELLULAR VESICLES USING FLOW CYTOMETRY - PITFALLS AND LIMITATIONS

Spittler A

Surgical Research Laboratories, Medical University of Vienna, Vienna, Austria

14:45 IL58 (O94)

PRO-COAGULANT POTENTIAL OF PLATELET-DERIVED MICROVESICLES

Tripisciano C, Weiss R, Eichhorn T, Weber V

Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis - Dep. Health Sciences and Biomedicine, Danube University Krems, Krems, Austria

15:00 IL59 (O95)

INFLUENCE OF ANTICOAGULATION ON CELL ACTIVATION AND MICROVESICLE GENERATION DURING LIPID APHERESIS

Weiss R1, Fischer M2, Weber V1 1 Christian Doppler Laboratory for Innovative Therapy Approach, Danube University Krems, Krems, Austria; 2 Center for Biomedical Technology, Department for Health Sciences and Biomedicine, Danube University Krems, Krems, Austria

15:15 DISCUSSION

Oral Session OS14 Liver and Cardiovascular Tissue Engineering O96-O101

Lecture Hall D

Chairmen: Cecile LEGALLAIS, Compiegne, France Krzysztof D. PLUTA, Warsaw, Poland

14:00 O96

HOW TO DETERMINE THE CONCENTRATION OF CELLS ENCAPSULATED IN ALGINATE-POLYETHERSULFONE MICROCAPSULES

Lewińska D, Kupikowska-Stobba B, Grzeczkowicz M



37

14:15 O97

LIVER TISSUE DECELLULARIZATION AS A TECHNOLOGY OBTAINING POROUS SCAFFOLD FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Bobrova M1, Safonova L1, Agapova O2, Krasheninnikov M3, Shagidulin M2, Agapov I2, Gautier S2 1 Biologocal Faculty, Lomonosov Moscow State University, Moscow, Russian Federation; 2 Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russian Federation; 3 I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation

14:30 O98

GENETICALLY MODIFIED FEEDER LAYER CELLS IN HEPATIC CELLS CULTURE

Zakrzewska K, Samluk A, Kowalska A, Pijanowska D, Pluta K


14:45 O99 PROCESSING OF HUMAN EXTRACELLULAR MYOCARDIAL MATRIX PRESERVES ITS CYTOPROTECTIVE EFFECTS

Becker M1, Kappler B1, Ma N1, Falk V2, Stamm C2 1 Berlin Center for Regenerative Therapies, Berlin, Germany; 2 Deutsches Herzzentrum Berlin, Berlin, Germany

15:00 O100

IL-6 PRESENT IN HEART FAILURE SERUM FACILITATES SERUM FACILITATES THE ADAPTATION OF CORD BLOOD MESENCHYMAL STROMAL CELLS TO HYPOXIC ENVIRONMENTS

Xu Z1, Nazari-Shafti T2, Bader A2, Falk V2, Stamm C2 1 Berlin Center for Regenerative Therapies, Berlin, Germany; 2 Deutsches Herzzentrum Berlin, Berlin, Germany

15:15 O101

CONTRIBUTION OF MESENCHYMAL STEM CELLS TO FIBROSIS

Fischer F

Health Sciences and Biomedicine, Danube University Krems, Austria

Special Symposium SP13 Vascular Tissue Engineering KL8, IL60-IL64, O107

Lecture Hall A

Organizer: Beat H. WALPOTH, Geneva, Switzerland Chairmen: Anna MALASHICHEVA, Saint-Petersburg, Russian

Federation, Giuseppe FAGGIAN, Verona, Italy

16:00 KL8

VASCULAR TISSUE ENGINEERING: DREAM OR REALITY?

Walpoth BH Department of Surgery, Geneva University Hospital, Geneva, Switzerland

16:30 IL60 (O102)

ADHESIVE AND CYTOTOXIC PROPERTIES OF POLYCAPROLACTONE, LACTIDE AND THEIR COPOLYMERS

Golovkin A1, Bolbasov E2, Tverdohlebov S2, Sinev A3, Mishanin A3, Malashicheva A3 1 Institute of Molecular Biology and Genetics, Federal Almazov Medical Research Centre, St. Petersburg, Russian Federation; 2 Tomsk Polytechnic University, Tomsk, Russian Federation; 3 Federal Almazov Medical Research Centre, St. Petersburg, Russian Federation

16:45 IL61 (O103)

ENGINEERED VASCULAR TISSUES BY MIMICKING THE NATIVE EXTRACELLULAR MATRIX

Zhao Q, Kong D

Key Laboratory of Bioactive Materials (Ministry of Education), Nankai University, 300071, Tianjin, China

17:00 IL62 (O104)

MODIFICATION OF POLYMER SURFACE USING RFMS TECHNIQUE FOR INCREASED BIOCOMPATIBILITY

Malchikhina A1, Bolbasov E1, Shesterikov E1, Golovkin A2, Anissimov Y3, Tverdokhlebov S1 1 Institute of Physics and Technology, National Research Tomsk Polytechnic University, Tomsk, Russian Federation; 2 Institute of molecular biology and genetics, Federal Almazov Medical Research Centre, St. Petersburg, Russian Federation; 3 School of Biomolecular and Physical Sciences, Griffith University, Brisbane, Australia

17:15 IL63 (O105)

DECELLULARIZED SMALL-DIAMETER VASCULAR PROSTHESIS FROM HUMAN PLACENTA CHORION

Schneider K1, Enayati M1, Grasl C2, Walter I3, Andreas T4, Redl H5, Wojta J6, Bergmeister H1 1 Department of Biomedical Research, Medical University of Vienna, Vienna, Austria; 2 Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; 3 Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria; 4 Institute for Biochemical Engineering, University of Applied Sciences, Technikum Wien, Vienna, Austria; 5 Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria; 6 Ludwig Boltzmann Institute of Cardiovascular Research, Vienna, Austria

17:30 IL64 (O106)

TAILORING THE FOREIGN BODY RESPONSE FOR IN SITU VASCULAR TISSUE ENGINEERING

Rothuizen TC, Damanik FFR, Lavrijsen T, Visser MJT, Hamming JF, Lalai RA, Duijs JMGJ, van Zonneveld AJ, Hoefer IE, van Blitterswijk CA, Rabelink TJ, Moroni L, Rotmans JI

Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

17:45 O107

IBTA-FABRICATED MICROBIOTUBE VASCULAR GRAFTS MET 1 YEAR’S PERFECT PATENCY IN A RAT MODEL

Ishii D1, Enmi J2, Iida H2, Kurisu K1, Nakayama Y3 1 Department of Neurosurgery, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; 2 Department of Investigative Radiology, National Cerebral and Cardiovascular Center, Osaka, Japan; 3 Division of Medical Engineering and Materials, National Cerebral and Cardiovascular Center, Osaka, Japan

Oral Session ESAO Annual Awards Session AL1-AL5

Lecture Hall B

Chairman: Ashraf W. KHIR, Uxbridge, UK

16:30

INTRODUCTION TO THE SESSION

Khir AW

Brunel Institute for Bioengineering, Brunel University London, Uxbridge, UK


38

16:35 AL1

A ROTARY BLOOD PUMP DESIGN TO REDUCE BLOOD TRAUMA

Thamsen B


17:00 AL2

DESIGN OF CENTRIFUGAL PUMPS FOR PRESSURE SENSITIVE, EFFICIENT AND BLOOD COMPATIBLE VENTRICULAR SUPPORT

Graefe R

Helmholtz Institute of Biomedical Engineering, RWTH Aachen University, Aachen, Germany

17:15 AL3

BIOLOGICAL AND MECHANICAL CHARACTERIZATION OF A BIOHYBRID BONE SUBSTITUTE REBUILT IN BIOREACTOR FOR MAXILLOFACIAL RECONSTRUCTION

Baudequin T

Université de Technologie de Compiègne, Compiègne, France

17:30 AL4

TAILORING THE FOREIGN BODY RESPONSE FOR IN SITU VASCULAR TISSUE ENGINEERING

Müller I1, Aigner P2 1 Department of Cardiovascular Engineering, RWTH Aachen, Aachen, Germany; 2 Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria

17:45 AL5

COAXIALLY ELECTROSPUN AND DIRECTIONAL SOLIDIFIED SCAFFOLDS FOR BONE AND VASCULAR TISSUE ENGINEERING

Garcia Garcia A1, Al Halabi F2 1 BioMechanics and BioEngineering Laboratory, Université de Technologie de Compiègne (UTC), Compiègne, France; 2 Institute for Multiphase Processes, Leibniz Universitaet Hannover, Germany

Oral Session OS15 Biomaterials in Contact with Blood O108-O112

Lecture Hall C

Chairmen: Birgit GLASMACHER, Hannover, Germany, Maciej GAWLIKOWSKI, Zabrze, Poland

16:30 O108

INSPIRED BY NATURE BILAYERED POLYURETHANE NANOFIBROUS SCAFFOLDS FOR SMALL DIAMETER TISSUE ENGINEERED VASCULAR GRAFTS

M. Wojasiński M, Ciach T

Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland

16:45 O109

IMMOBILIZATION STRATEGIES FOR GLYCOSAMINOGLYCANS ON BIOMATERIALS FOR ANTI-INFLAMMATORY PURPOSES

Al-Khoury H

Biomedical Materials Group Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany

17:00 O110

SURFACE THROMBOGENICITY EVALUATION OF NEW INNOVATIVE BIOMATERIAL

Janiczak K1, Zawidlak-Węgrzyńska B1, Cieśla P1, Gawlikowski M1, Kościelniak-Ziemniak M1, El Fray M2, Kustosz R1 1 Artificial Heart Labolatory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Polymer Institute, West Pomerania University of Technology, Szczecin, Poland

17:15 O111

A DUAL DRUG DELIVERY SYSTEM (DDS) MADE BY ELEC-TROSPINNING AGAINST THROMBOSIS IN CARDIOVASCULAR DISEASES

Repanas A, Mueller M, Al Halabi F, Bode M, Glasmacher B

Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany

17:30 O112

IN-VITRO EVALUATION OF THE POLISH PAEDIATRIC VAD RELIGA HEART PED THROMBOGENICITY

Gawlikowski M, Janiczak K, Głowacki M, Cieśla P, Kustosz R


Special Symposium SP14 Advances in Regional Citrate-Calcium Anticoagulation IL65, IL66, O113-O115

Lecture Hall D

Chairmen: Martin BRANDL, Krems, Austria, Jens HARTMANN, Krems, Austria

16:30 IL65

CITRATE ANTICOAGULATION IN APHERESIS AND TANDEM APHERESIS/HEMODIALYSIS PROCEDURES

Buturović-Ponikvar J

Department of Nephrology, University of Ljubljana, Ljubljana, Slovenia

16:50 IL66

REGIONAL CITRATE ANTICOAGULATION A FUTURE OF HEMODIALYSIS: A CRITICAL EVALUATION BASED ON MORE THAN 10 000 CITRATE PROCEDURES PER YEAR IN A SINGLE CENTER

Ponikvar R

Department of Nephrology, University of Ljubljana, Ljubljana, Slovenia

17:10 O113

MODELLING AND SIMULATION OF A TARGET-ORIENTATED ALGORITHM FOR RCA

Brandl M1, Kellner K1, Strobl K2, Hartmann J2 1 Center for Integrated Sensor Systems, Danube University Krems, Krems, Austria; 2 Center for Biomedical Technology, Danube University Krems, Krems, Austria

17:25 O114

CITRATE ANTICOAGULATION IMPROVES BLOOD COMPATIBILITY IN DIALYSIS AND AHPERESIS – DATA FROM IN VITRO EXPERIMENTS

Harm S, Hartmann J

Center for Biomedical Technology, Danube University Krems, Krems, Austria

17:40 O115

INFLUENCE OF MAGNESIUM ON COAGULATION DURING CITRATE ANTICOAGULATION: AN IN-VITRO STUDY

Strobl K, Hartmann J

Department for Health Sciences and Biomedicine, Danube University Krems, Krems, Austria

Plenary Lectures, Special Symposia and Oral Sessions Saturday, September 17th

39

SATURDAY, September 17th

Oral Session OS16 VADs in Daily Activity and Excercise O116-O121

Lecture Hall A

Chairmen: Arianna Di MOLFETTA, Rome, Italy, Francesco MOSCATO, Vienna, Austria

8:30 O116

FULL OR PARTIAL LEFT VENTRICULAR ASSIST DEVICE SUPPORT: COMPUTATIONAL ASSESSMENT OF HEMODYNAMICS

Caruso M1, Renzulli A2, Fragomeni G2 1 DIMEG, University of Calabria, Rende, Italy; 2 Medical and Surgical Science Department, Magna Graecia University of Catanzaro, Catanzaro, Italy

8:45 O117

EXERCISE PHYSIOLOGY IN HEART FAILURE: A SIMULATION STUDY

Fresiello L1, Meyns B1, Di Molfetta A2, Ferrari G3 1 Cardiac Surgery, KU Leuven, Leuven, Belgium; 2 Medical and Surgical Department of Pediatric Cardiology, Pediatric Hospital Bambino Gesù, Rome, Italy; 3 Institute of Clinical Physiology, National Research Council, Rome, Italy

9:00 O118

PRESSURE AND VOLUME UNLOADING DURING RAMP TESTS IN PATIENTS SUPPORTED WITH A LEFT VENTRICULAR ASSIST DEVICE: A MODEL STUDY

Moscato F1, Gross C1, Dimitrov K2, Zimpfer D1, Schima H1 1 Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; 2 Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria

9:15 O119

TEMPORARY CARDIAC UNLOADING DURING EVOLVING MYOCARDIAL INFARCTION DRASTICALLY REDUCES MORTALITY: PERSPECTIVES FROM A SWINE MODEL

Trivella M1, Piersigilli A2, Bernini F2, Pelosi G1, Burchielli S3, Puzzuoli S2, Kusmic C1, L’Abbate A2 1 Department of Biomedicine, CNR-Clinical Physiology Institute, Pisa, Italy; 2 Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy; 3 Fondazione Toscana Gabriele Monasterio, Pisa, Italy

9:30 O120

WHAT DETERMINES EXERCISE CAPACITY IN LVAD PATIENTS? A MULTIPLE REGRESSION ANALYSIS STUDY

Fresiello L1, Jacobs S1, Timmermans P2, Meyns B1 1 Clinical Cardiac Surgery Department, KU Leuven, Leuven, Belgium; 2 Department of Cardiology, University Hospital of KU Leuven, Leuven, Belgium

9:45 O121

MONITORING OF PHYSICAL ACTIVITY IN PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE IMPLANTED

Gross C1, Haller M1, Zimpfer D2, Schima H1, Moscato F1 1 Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; 2 Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria

Oral Session OS17 Computer Modelling in Hemodialysis O122-O127

Lecture Hall B

Chairmen: Detlef H. KRIETER, Wuerzburg, Germany Jacek WANIEWSKI, Warsaw, Poland

8:30 O122

FINITE ELEMENT MODELING OF SODIUM EXCHANGE IN THE HOLLOW FIBER OF A HAEMODIALYZER

Ravagli E1, Perazzini C2, Severi S1 1 Department of Electrical, Electronic and Information Engineering, University of Bologna, Bologna, Italy; 2 Health Sciences and Technology Interdepartmental Center for Industrial Research, University of Bologna, Bologna, Italy

8:45 O123

ANALYSIS OF THE EFFECT OF GEOMETRICAL AND OPERATIONAL PARAMETERS ON SOLUTE TRANSPORT IN HOLLOW FIBER DIALYZERS WITH A TWO-DIMENSIONAL TRANSPORT MODEL

Donato D1, Boschetti-de-Fierro A2, Zweigart C2, Eloot S3, Storr M2, Krause B2, Leypoldt K4, Segers P1 1 IBiTech − bioMMeda, Department of Electronics and Information Systems, iMinds Medical IT, Ghent University, Ghent, Belgium; 2 Research and Development, Gambro Dialysatoren GmbH, Hechingen, Germany; 3 Nephrology, Dialysis unit 1P8, Ghent University Hospital, Ghent, Belgium; 4 Baxter Healthcare Corporation, Deerfield, USA

9:00 O124

INTEGRATED MODEL FOR PHOSPHATE AND CALCIUM KINETICS DURING WEEKLY CYCLE OF HEMODIALYSIS

Waniewski J, Dębowska M


9:15 O125

IN VIVO CHARACTERIZATION OF FRACTIOPES® 200, A NEW PLASMA FRACTIONATOR MEMBRANE FOR LIPID APHERESIS

Krieter D1, Lange F1, Bonn F2, Sauvant C3, Lemke H3, Wanner C1 1 Division of Nephrology, University Hospital Wuerzburg, Wuerzburg, Germany; 2 Membranes Business Unit, 3M, Wuppertal, Germany; 3 R & D, eXcorLab GmbH, Obernburg, Germany

9:30 O126

DOES THE PERITONEAL FLUID ABSORPTION DEPEND ON THE TONICITY OF DIALYSATE? – INSIGHTS FROM THE TWO-PHASE DISTRIBUTED MODELING

Stachowska-Pietka J1, Lindholm B2, Waniewski J1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

9:45 O127

A NOVEL ANALYTICAL MODEL PREDICTING THE COURSE OF HEMATOCRIT ALONG THE LENGTH OF DIALYZER’S FIBERS

Poorkhalil A1, Mouzakis F1, Amoabediny G2, Kashefi A1, Mottaghy K1 1 Institute of Physiology, RWTH Aachen University, Aachen, Germany; 2 Research Center for New Technologies in Life Science Engineering, University of Tehran, Tehran, Islamic Republic of Iran


40

Oral Session OS18 Artificial Pancreas and Diabetes Treatment O128-O133

Lecture Hall C

Chairmen: Joseph KOST, Beer-Sheva, Israel Piotr LADYZYNSKI, Warsaw, Poland

8:30 O128

NANOTECHNOLOGY FOR TARGETED DRUG AND GENE THERAPIES

Kost J

Chemical Enginerring, Ben-Gurion University, Beer-Sheva, Israel

9:00 O129

THE INFLUENCE OF THE VOICEDIAB SYSTEM ON METABOLIC CONTROL IN PATIENTS WITH TYPE I DIABETES

Foltyński P1, Ładyżyński P1, Pańkowska E2, Mazurczak K2 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Department of Pediatrics, The Institute of Mother and Child, Warsaw, Poland

9:15 O130

BED SIDE ARTIFICIAL PANCREAS WITH CLOSED-LOOP SYSTEM AND SURGICAL DIABETES TREATMENT

Hanazaki K1, Munekage M1, Kitagawa H1, Yatabe T2, Asano T3, Kinoshita Y3, Namikawa T1 1 Surgery 1, Kochi Medical School, Nankoku, Japan; 2 Anesthesiology, Kochi Medical School, Nankoku, Japan; 3 Nikkiso Co LTD, Tokyo, Japan

- O131 WITHDRAWN

9:30 O132

CHALLENGES AND RESULTS FOR THE ARTIFICIAL PANCREAS: THE CONTROL SYSTEMS PERSPECTIVE

Cusimano V, Palumbo P

CNR - Institute of Systems Analysis and Computer Science A. Ruberti, Roma, Italy

9:45 O133 WITHDRAWN

Oral Session OS19 Computer Modelling in Respiratory System and Others O134-O139

Lecture Hall D

Chairmen: Gianfranco FERRARI, Rome, Italy, Marek DAROWSKI, Warsaw, Poland

8:30 O134

COMPARISON OF AEROSOL ACCESSORIES PERFORMANCES BY A FLUID DYNAMIC COMPUTATIONAL APPROACH

Possenti L, Casagrande G, Costantino M


8:45 O135

VIRRESPIR - A VIRTUAL PNEUMONOLOGICAL PATIENT IN THE FORM OF WEB APPLICATION

Gólczewski T, Zieliński K, Stecka A, Ładyżyński P


9:00 O136

NUMERICAL SIMULATIONS OF THE LUNG AND HEART DISEASES COMORBIDITY

Zieliński K1, Gólczewski T1, Ferrari G2, Górczyńska K1, Kozarski M1, Darowski M1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Section of Rome, Cardiovascular Engineering, CNR - Institute of Clinical Physiology, Rome, Italy

9:15 O137

GEOMETRY FACTOR IN CONTINUOUS INDUCTIVE POWERING AND INDUCTIVE RECHARGING OF IMPLANTED MEDICAL DEVICES

Danilov A, Mindubaev E, Selishchev S

Biomedical Engineering Department, National Research University of Electronic Technology (MIET), Moscow, Russian Federation

9:30 O138

FINITE ELEMENT ANALYSIS OF MINI-PLATE STABILIZATION OF MANDIBLE FRACTURE

Wądołowski P1, Krzesiński G1, Gutowski P2 1 The Faculty of Power and Aeronautical Engineering, Warsaw University of Technology, Warsaw, Poland; 2 Department of Cranio-Maxillo-Facial Surgery, Medical University of Warsaw, Warsaw, Poland

9:45 O139

SIMULATION OF MASS TRANSPORT DURING INTRAPERITONEAL CHEMOTHERAPY: A PARAMETRICAL MODEL OF SINGLE TUMOR NODULES

Steuperaert M1, Falvo D’Urso Labate G2, Debbaut C1, Ceelen W3, Segers P1 1 IbiTech-BioMMeda, Ghent University, Ghent, Belgium; 2 Department of Environmental and Chemical Engineering, University of Calabria, Rende, Cosenza, Italy; 3 Department of Surgery, Ghent University, Ghent, Belgium

Plenary Lecture 4

Lecture Hall A

Chairman: Piotr LADYZYNSKI, Warsaw, Poland

10:10 PL4 TECHNOLOGY FOR DETECTING HYPOGLYCEMIA

David C. Klonoff U.C. San Francisco, School of Medicine, Diabetes Research Institute Mills-Peninsula Health Services, San Mateo, CA, USA


41

Special Symposium WG2 Heart Working Group Symposium MCS research and regulations IL77-IL81, KL9

Lecture Hall A

Chairmen: Klaus AFFELD, Berlin, Germany, Ulrich STEINSEIFER, Aachen, Germany

Part 1 Update on MCS Research in Europe

11:00 IL77 OPTIMIZING MCS HEMODYNAMICS THROUGH LUMPED PARAMETER MODELS

Di Molfetta A

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy

11:10 IL78 SMARTER PUMPS: HEMODYNAMIC MONITORING AND PHYSIOLOGICAL CONTROL

Moscato F

Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria

11:20 IL79 BETTER PUMPS: OPTIMIZING PUMP PERFORMANCE THROUGH FLOW SIMULATION

Kaufmann T

Department of Cardiovascular Engineering, RWTH Aachen, Institute of Applied Medical Engineering, Aachen, Germany

11:30 IL80 BLOOD DAMAGE AND THROMBUS FORMATION IN MCS SYSTEMS

Kertzscher U


11:40 IL81 LIMITATIONS IN EXERCISE CAPACITY IN VAD PATIENTS

Meyns B

Cardiac Surgery, KU Leuven, Leuven, Belgium

Part 2 The Impact of Changing Medical Device Regulations on MCS Research in Europe

11:50 KL9 NEW MEDICAL DEVICE REGULATIONS AFFECTING MCS RESEARCH

Schima H Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Ludwig Boltzmann Gesellschaft, Vienna, Austria

Special Symposium WG3 EUTox Working Group Symposium - CME Course IL67-IL70

Lecture Hall B

Chairman: Joachim JANKOWSKI, Aachen, Germany

11:00 IL67

FUTURE OF ANAEMIA MANAGEMENT IN CHRONIC KIDNEY DISEASE PATIENTS

Wiecek A

Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland

11:20 IL68

MINERAL AND BONE DISORDERS IN CHRONIC KIDNEY DISEASE

Spasovski G1, Rodriguez M2

1 Department of Nephrology, Ss. Cyril and Methodius University, Skopje, The Former Yugoslav Republic of Macedonia; 2 Maimonides Institute for Research in Biomedicine of Cordoba/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain

11:40 IL69

NUTRITION IN CHRONIC KIDNEY DISEASE PATIENTS

Vanholder R

Department of Internal Medicine, University Hospital Ghent, Ghent, Belgium

12:00 IL70

EXTRACELLULAR VOLUME AND BLOOD PRESSURE IN CHRONIC KIDNEY DISEASE

Argiles A


12:20 DISCUSSION

Special Symposium SP15 How to Prevent Hypoglycemia? Symposium in memory of Prof. Jan. M. Wojcicki Symposium Co-sponsored by the Internatinal Centre of Biocybernetics and Diabetes Technology Society

IL71-IL75

Lecture Hall C

Chairmen: David C. KLONOFF, San Mateo, USA, Piotr LADYZYNSKI, Warsaw, Poland

11:00 IL71

WELCOMING REMARKS AND MEMORY OF JAN WOJCICKI

Klonoff DC

Diabetes Research Institute Mills-Peninsula Health Services, San Mateo, USA

11:10 IL72

CONTROVERSIES IN DEFINING HYPOGLYCEMIA FOR RESEARCH AND CLINICAL PURPOSES

Vigersky R

Walter Reed National Military Medical Center, Washington DC, USA

11:30 IL73

THE RISKS OF UNDETECTED HYPOGLYCEMIA

Pańkowska E

Warsaw Institute of Diabetology, Warsaw, Poland

11:50 IL74

OPEN LOOP TECHNOLOGY TO PREVENT HYPOGLYCEMIA

Pickup J

King’s College London, London, UK

12:10 IL75

CLOSED LOOP TECHNOLOGY TO PREVENT HYPOGLYCEMIA

Hovorka R

Institute of Metabolic Science, University of Cambridge, Cambridge, UK


42

Special Symposium SP16 Extracorporeal Lung Support and Lung Transplantation IL76, O140-O144

Lecture Hall D

Organizer & Chairman: Khosrow MOTTAGHY, Aachen, Germany

11:00 IL76

EXTRACORPOREAL LUNG SUPPORT TO TRANSPLANTATION?

Spillner J

Department of Cardiac and Thorax Surgery, RWTH Aachen University, Aachen, Germany

11:20 O140

OXYGEN DIFFUSION THROUGH LUNG SURFACTANT USING FLUOROCARBON IN AN ARTIFICIAL ALVEOLAR CHAMBER

Khachab A1, Hahn A2, Mottaghy K1 1 Institute of Physiology, RWTH Aachen University, Aachen, Germany; 2 Federal Institute for Risk Assessment (BR), Berlin, Germany

11:30 O141

ENDOXY: ENDOTHELIAL CELLS IN BIOHYBRID LUNGS PROMOTE NOT ONLY HEMOCOMPATIBILITY BUT ALSO GAS TRANSFER PERFORMANCE

Menzel S1, Jockenhoevel S2, Cornelissen C3 1 Dept. of Tissue Engineering & Textile Implants, Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany; 2 Department of Tissue Engineering & Textile Implants, Institut für Textiltechnik and Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany; 3 Department for Internal Medicine - Section for Pneumology, Medical Faculty, RWTH Aachen University, Aachen, Germany

11:45 O142

SURFACE MODIFICATION OF SILICONE TUBES BY FUNCTIONAL CARBOXYL AND AMINE, BUT NOT PEROXIDE GROUPS, AND COLLAGEN IMMOBILIZATION IMPROVES CELL STABILITY

Salehi-Nik N1, Zandieh-Doulabi B2, Amoabediny G3, Klein-Nulend J1, Mottaghy K4 1 School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Islamic Republic of Iran; 2 Oral Cell Biology, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, MOVE Research Institute Amsterdam, Amsterdam, The Netherlands; 3 Department of Biomedical Engineering, Research Center for New Technologies in Life Science Engineering, University of Tehran, Tehran, Islamic Republic of Iran; 4 Institute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany

12:00 O143

DEVELOPMENT OF AN ULTRA COMPACT AND DURABLE ECMO SYSTEM AND A LONG-TERM EVALUATION BY CHRONIC ANIMAL EXPERIMENT

Katagiri N, Tatsumi E, Takewa Y, Tsukiya T, Mizuno T, Taenaka Y

Artificial Organs, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

12:15 O144 WITHDRAWN

43

POSTER SESSIONS

THURSDAY, September 15th

Poster Session I

15:30 – 16:30

Poster Area

Cardiovascular: Pump development (PS1) P1-P11

Chairmen: Ashraf W. KHIR, Uxbridge, UK, Krzysztof ZIELINSKI, Warsaw, Poland

P1 BLOOD FLOW ESTIMATION OF THE POLVAD-MEV VENTRICULAR ASSIST DEVICE BASED ON STANDARD MEASUREMENTS SIGNALS FROM SUPPLY UNIT

Siewnicka A, Janiszowski K

Institute of Automatic Control and Robotics, Warsaw University of Technology, Warsaw, Poland

P2 OPTIMIZATION OF A TRANSCUTANEOUS ENERGY TRANSFER SYSTEM TOPOLOGY FOR STABLE INDUCTIVE POWERING OF MECHANICAL CIRCULATORY SUPPORT SYSTEMS

Danilov A, Mindubaev E, Selishchev S

Biomedical Engineering Department, National Research University of Electronic Technology (MIET), Moscow, Russian Federation

P3 PRECISION MATCHING PULSATILE BLOOD PUMP

Yang M, Zhuang X, Meng F, Xu Z, Ouwen C, Xu L, Li S, Lu C

Instrument Science and Eng., Shanghai Jiaotong University, Shanghai, China

P4 PROGRESS AND IN VITRO EXPERIENCE OF OUR IMPLANTABLE PEDIATRIC PUMP

Itkin G, Sysoev A, Dmitrieva O, Nevzorov A, Filatov I, Gotier S

V.I. Shumakov Federal Research Center of transplantology and artificial organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation

P5 DESIGN OF MINIATURE MOTOR FOR CENTRIFUGAL BLOOD PUMP RELIGA HEART® ROT

Darłak M, Altyntsev I, Kustosz R, Jaworek M


P6 DEVELOPMENT OF LVAD SYSTEM BASED ON MECHATRONIC UNIT WITH UNI-DIRECTIONAL MOTION CONVERTER

Morozov V, Zhdanov A, Belyaev L

Department of Mechanical Engineering, Vladimir State University named after Alexander and Nikolay Stoletovs, VLSU, Moscow, Russian Federation

P7 STATIC AND DYNAMIC CHARACTERISTICS OF A MINIMALLY INVASIVE HEART CATHETER PUMP

Janeczek C1, Karabegovic A1, Hinteregger M1, Willinger R2, Gföhler M1 1 Institute for Engineering Design and Logistics Engineering, Department of Machine Design and Rehabilitation Engineering, TU Wien, Vienna, Austria; 2 Institute for Energy Systems and Thermodynamics, Department of Fluid-Flow Machinery, TU Wien, Vienna, Austria

P8 RESULTS OF IN-VITRO TESTS ON A 1:1 PROTOTYPE OF A PERCUTANEOUS VENTRICULAR ASSIST DEVICE

Karabegovic A, Janeczek C, Hinteregger M, Gföhler M

Institute for Engineering Design and Logistics Engineering, Vienna University of Technology, Vienna, Austria

P9 IMPLEMENTATION AND INDUSTRIALIZATION PROCESS OF THE POLISH PEDIATRIC EXTRACORPOREAL VENTRICULAR ASSIST DEVICE

Gonsior M, Kustosz R, Kapis A, Bujok W, Szuber-Dynia A, Zawidlak-Węgrzyńska B, Świątek M, Zalewski J


P10 PIV TESTS ON PEDIATRIC VENTRICLE ASSIST DEVICES: EFFECTS OF THE HEART RATE ON THE VAD OPERATION

Witkowski D


P11 THE INNOVATIVE POLISH LONG TERM HEART SUPPORT SYSTEM DEVELOPMENT

Darłak M, Kustosz R, Altyntsev I, Gonsior M, Gawlikowski M, Głowacki M


Cardiovascular: Hydro- and Hemodynamics of Cardiac Assist Devices (PS2) P12-P21

Chairmen: Steven JACOBS, Leuven, Belgium, Roman KUSTOSZ, Zabrze, Poland

P12 OPTICAL VALIDATION OF ULTRASONIC MICROOBJECTS DETECTION

Pydziński P, Gawlikowski M


P13 FLOW VISUALIZATION INSIDE THE BLOOD PUMP OF THE 30 CC PULSATILE PEDIATRIC VENTRICULAR ASSIST DEVICE

Belyaev L, Zhdanov A, Morozov V


Poster Sessions Thursday, September 15th

44

P14 DEVELOPMENT AND ASSESSMENT OF PASSIVE BEATING RIGHT HEART PLATFORM FOR CARDIOVASCULAR DEVICES TESTING AND REALISTIC SURGICAL TRAINING

Jaworek M1, Lucherini F1, Gelpi G2, Antona C2, Fiore G1, Vismara R1 1 Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy; 2 Cardiovascular Department, 'Luigi Sacco' General Hospital, Milan, Italy

P15 REPERFUSION OF PIG HEARTS FROM FOREGOING ANIMAL TRIALS AFTER EUTHANASIA IN AN ISOLATED HEART APPARATUS

Buesen M1, Ernst L2, Tolba R2, Steinseifer U1 1 Dept. of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany; 2 Institute for Laboratory Animal Science & Experimental Surgery, RWTH Aachen University Hospital, Aachen, Germany

P16 THE APPLICATION OF SWINE AS AN EXPERIMENTAL MODEL FOR LONG TERM CARDIAC SUPPORT

Janiczak K1, Kustosz R1, Gonsior M1, Gawlikowski M1, Głowacki M1, Cieśla P1, Ścigała P2, Czingon M3, Zawidlak-Węgrzyńska B1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Clinic for Animals, Piekary Slaskie, Poland; 3 Clinic for Animals, Zabrze, Poland

P17 AORTIC VALVE CLOSING THROUGH APICAL CANNULA DURING MECHANICAL CIRCULATORY SUPPORT WITH BERLINHEART EXCOR SYSTEM IN 4-YEAR OLD CHILD

Śliwka J1, Pawlak S1, Przybylski R1, Grzybowski A1, Włoczka G1, Białkowski J2 1 Department of Cardiac Surgery, Transplantology and Mechanical Circulatory Support in Children, Silesian Center for Heart Diseases, Zabrze, Poland; 2 Department of Pediatric Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland

P18 CONCOMITANT USE OF CONTINUOUS FLOW AND PULSATILE FLOW VAD IN BIVENTRICULAR AND UNIVENTRICULAR PHYSIOLOGY: A SIMULATION STUDY

Di Molfetta A1, Ferrari G2, Fresiello L3, Iacobelli R1, Filippelli S1, Amodeo A1 1 Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 2 Section of Rome, Cardiovascular engineering, CNR - Institute of clinical Physiology, Rome, Italy; 3 Department of Cardiac Surgery, KU-Leuven, Leuven, Belgium

P19 ACUTE BIVENTRICULAR INTERACTION IN PEDIATRIC PATIENTS IMPLANTED WITH CONTINUOUS FLOW AND PULSATILE FLOW LVAD: A SIMULATION STUDY

Di Molfetta A1, Ferrari G2, Iacobelli R1, Filippelli S1, Fresiello L3, Amodeo A1 1 Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 2 Section of Rome, Cardiovascular engineering, CNR - Institute of clinical Physiology, Rome, Italy; 3 Department of Cardiac Surgery, KU-Leuven, Leuven, Belgium

P20 EVOLUTION OF MITRAL REGURGITATION IN BERLIN HEART EXCOR LVAD PATIENTS LESS THAN 10KG

Di Molfetta A1, Iacobelli R1, Ferrari G2, Filippelli S1, Adorisio R1, Amodeo A1 1 Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 2 Section of Rome, Cardiovascular Engineering, CNR - Institute of clinical Physiology, Rome, Italy

P21 CARDIAC AND PLASMA LEVELS OF IL-33/ST2 SYSTEM IN PEDIATRIC PATIENTS WITH HEART FAILURE UNDERGOING VENTRICULAR ASSIST DEVICE SUPPORT

Ragusa R1, Di Molfetta A2, Cabiati M3, Pitto L3, Del Ry S3, Amodeo A2, Trivella M3, Caselli C3 1 Scuola Superiore Sant Anna, Pisa, Italy; 2 Cardiothoracic surgery, Ospedale Bambin Gesu di Roma, Rome, Italy; 3 Laboratory of Cardiovascular Biochemistry, CNR Institute of Clinical Physiology, Pisa, Italy

Cardiovascular: Modelling in silico and in vitro (PS3) P22-P30

Chairmen: Libera FRESIELLO, Leuven, Belgium, Marek DAROWSKI, Warsaw, Poland

P22 COMPUTATIONAL FLUID DYNAMICS ANALYSIS OF HYDRODYNAMIC BEARINGS UNDER PULSING FLOW CONDITIONS IN BLOOD PUMP

Han Q, Li H

School of Mechanical Engineering, University of Jinan, Jinan, China

P23 SETTING UP A PAEDIATRIC PNEUMATIC VAD: A HYBRID MODEL STUDY

Ferrari G1, Di Molfetta A2, Zieliński K3, Fresiello L4, Górczyńska K3, Pałko KJ3, Darowski M13, Amodeo A2, Kozarski M3 1 Section of Rome, Cardiovascular engineering, CNR - Institute of clinical Physiology, Rome, Italy; 2 Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 3 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 4 Clinical Cardiac Surgery Department, KU Leuven, Leuven, Belgium

P24 INVESTIGATION OF HYDRODYNAMIC BEARING FOR RELIGA HEART® ROT CENTRIFUGAL BLOOD PUMP

Altyntsev I, Darlak M, Kustosz R


P25 FORCE BALANCE IN RELIGA HEART® ROT CENTRIFUGAL BLOOD PUMP

Altyntsev I, Darlak M, Kustosz R


P26 COMPARISON OF THE FLOW PATTERN OBTAINED WITH NUMERICAL SIMULATIONS AND PIV MEASUREMENTS

Obidowski D, Reorowicz P, Jodko D, Witkowski D, Jóźwik K


P27 BLOOD PARAMETERS INVESTIGATION TO DEFINE BEST NUMERICAL AND IN VITRO TESTING CONDITIONS TO BENCHMARK VAD PERFORMANCE

Molteni A, Chan C

Calon Cardio-Technology Ltd, Swansea, UK

P28 MATLAB/ SIMULINK MODELING OF MECHATRONIC LVAD UNIT WORKING IN CHRONIC HEART FAILURE

Zhdanov A, Shtyh D, Belyaev L, Morozov V



45

P29 NUMERICAL INVESTIGATION OF BLOOD FLOW IN A STENOTIC VASCULAR USING MULTIPHASE MODEL

Gou Z1, Ruan X1, Qian W2, Zou J1, Fu X1 1 State Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou, China; 2 Cardiothoracic Surgery Department, Zhejiang Provincial People’s Hospital, Hangzhou, China

P30 FORMAL MODELLING AND ANALYSIS TOOL APPLIED TO DEVELOPMENT OF VAD SAFETY CONTROL SYSTEM

Cavalheiro A1, Santos Filho D2, Andrade A3, Fonseca J3 1 Engeneer, Fundacao Santo Andre, Sao Paulo, Brazil; 2 Engenharia, Escola Politecnica da USP, Sao Paulo, Brazil; 3 Bioengeneer, Instituto Dante Pasanezze de Cardiologia, Sao Paulo, Brazil

Artificial circulation (Lung, ECMO and Liver) (PS4) P31-P42

Chairmen: Pedro M. BAPTISTA, Zaragoza, Spain Khosrow MOTTAGHY, Aachen, Germany

P31 COMPARISON OF BLOOD OXYGENATION IN SINGLE AND DUAL CANNULATION FOR ADULT EXTRACORPOREAL MEMBRANE OXYGENATION

Togo K1, Takewa Y2, Katagiri N2, Fujii Y2, Tateishi S3, Tatsumi E2 1 Health Medical, Teikyo Heisei University, Tokyo, Japan; 2 Artificial Organs, National Cerebral and Cardiovascular Center, Osaka, Japan; 3 CA/CP Business Unit, Maquet Japan, K.K., Tokyo, Japan

P32 USING A NEW HYBRID RESPIRATORY SIMULATOR TO STUDY THE INFLUENCE OF VENTILATION PARAMETERS ON WORK OF BREATHING IN SMALL CHILDREN

Stankiewicz B, Pałko KJ, Darowski M, Zieliński K, Kozarski M


P33 A NEW RESPIRATORY TRAINING SYSTEM WITH A CONTROLLED CO2 ELIMINATION FOR HIGH ALTITUDE TRAINING

Mouzakis F1, Poorkhalil A1, Tabesh H2, Kashefi A1, Mottaghy K1 1 Institute of Physiology, RWTH Aachen University, Aachen, Germany; 2 Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Islamic Republic of Iran

P34 COAGULATION PATTERNS DURING AND AFTER CARDIOPULMONARY BYPASS DETECTED WITH THROMBELASTOGRAPHY

Hajek R1, Fluger I1, Zezula R1, Maderova K1, Prikrylova K1, Zuscich O1, Lonsky V1, Ruzickova J2 1 Cardiac Surgery, University Hospital Olomouc, Olomouc, Czech Republic; 2 Management, Central Moravian Hospital Group, Prostejov, Czech Republic

P35 NEW BIDIRECTIONAL ARTERIAL PERFUSION DEVICE

Abdel-Sayed S1, Favre J2, Wilhelm M3, Maisano F3, von Segesser L2 1 Surgery, University hospital-CHUV, Lausanne, Switzerland; 2 Department of Musculoskeletal Medicine, University hospital-CHUV, Lausanne, Switzerland; 3 Department of Cardio-Vascular Surgery, University Hospital, Zurich, Switzerland

P36 THE PERSPECTIVES FOR APPLICATION OF THE BLOOD PHOTOBIOMODULATION DURING EXTRACORPOREAL CIRCULATION

Walski T1, Drohomirecka A2, Wąż G3, Trochanowska N1, Gałecka K1, Czerski A4, Witkiewicz W5, Komorowska M1 1 Department of Biomedical Engineering, Wroclaw University of Science and Technology, Wroclaw, Poland; 2 Institute of Cardiology, Warsaw, Poland; 3 Medinet Heart Center Ltd., Wroclaw, Poland; 4 Department of Animal Physiology and Biostructure, University of Environmental and Life Sciences, Wroclaw, Poland; 5 Research and Development Centre, Regional Specialist Hospital in Wroclaw, Wroclaw, Poland

P37 ROLE OF PROSTAGLANDINS IN NORMOTHERMIC LIVER MACHINE PERFUSION

Rivera A1, Sierra A1, Chuvieco S1, Fernandez-Lopez I1, Gutierrez-Gutierrez J1, Sanchez del Arco R1, Gullon L2, Asencio J3, Del Cañizo J2 1 Department of Surgery, Universidad Complutense, Madrid, Spain; 2 Artificial Circulation Laboratory (LCA). Experimental Surgery Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain; 3 Department of General Surgery., Hospital General Universitario Gregorio Marañon, Madrid, Spain

P38 A MULTISCALE FRAMEWORK FOR STUDYING VASCULAR MORPHOLOGY ALTERATIONS DURING LIVER CIRRHOGENESIS: A FEASIBILITY STUDY

Peeters G1, Debbaut C1, Detrez J2, De Vos W2, Cornillie P3, Vandecasteele T3, De Schryver T4, Monbaliu D5, Laleman W5, Segers P1 1 Department of Electronics and Information Systems, Ghent University, Ghent, Belgium; 2 Department of Veterinary Sciences, University of Antwerp, Antwerpen, Belgium; 3 Department of Morphology, Ghent University, Ghent, Belgium; 4 UGCT, Ghent University, Ghent, Belgium; 5 University Hospitals Leuven, KU Leuven, Leuven, Belgium

P39 THE ROLE OF DEOXYCHOLIC ACID IN LIVER NORMOTHERMIC PERFUSION

Gutierrez-Gutierrez J1, Sanchez del Arco R1, Gullon L1, Chuvieco S1, Fernandez I1, Asencio J2, Del Cañizo J1 1 Department of Surgery. Universidad Complutense de Madrid, Laboratorio de Circulacion Artificial. Hospital General Universitario Gregorio Maranon, Madrid, Spain; 2 General Surgery Department, HGUGM, Madrid, Spain

P40 SINGLE COMPARTMENT MODEL FOR KINETICS OF BILE ACIDS DURING EXTRACORPOREAL LIVER SUPPORT THERAPY

Jung A1, Krisper P2, Korohoda P3, Stadlbauer-Köllner V2, Stauber R2, Schneditz D4 1 Department of Medical Physics and Biophysics, AGH University of Science and Technology, Cracow, Poland; 2 Department of Internal Medicine, Medical University of Graz, Graz, Austria; 3 Department of Electronics, AGH University of Science and Technology, Cracow, Poland; 4 Institute of Physiology, Medical University of Graz, Graz, Austria

P41 LASER-BASED MEASUREMENTS OF AIRBORNE PARTICLES GENERATED BY NEBULIZERS

D'Avenio G, Daniele C, Grigioni M

Technolgy and Health, Istituto Superiore di Sanità, Rome, Italy

P42 WITHDRAWN


46

Organ Tissue Engineering (PS5) P43-P53

Chairmen: Cecile LEGALLAIS, Compiegne, France, Nuno M. NEVES, Guimarães, Portugal

P43 TRANSCRIPTIONAL SELECTION AND MAINTENANCE OF INDUCED CARDIOMYOCYTE PRECURSOR CELLS CREATED BY DIRECT REPROGRAMMING

Bachamanda Somesh D1, Klose K1, Protze S2, Kunkel D1, Gossen M1, Falk V3, Stamm C3 1 Berlin Center for Regenerative Therapies, Berlin, Germany; 2 McEwen Center for Regenerative Medicine, Toronto, Canada; 3 Deutsches Herzzentrum Berlin, Berlin, Germany

P44 ONE RESULT ABOUT GROWTH ADAPTATION OF A BIOTUBE VASCULAR GRAFT IN A RAT MODEL

Ishii D1, Enmi J2, Iida H2, Kurisu K1, Nakayama Y3 1 Department of Neurosurgery, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; 2 Department of Investigative Radiology, National Cerebral and Cardiovascular Center, Suita, Japan; 3 Division of Medical Engineering and Materials, National Cerebral and Cardiovascular Center, Suita, Japan

P45 THE OXYGENE PARTIAL PRESSURE IN THE CULTURE OF HUVECS PERFORMED IN THE CAPILLARY MEMBRANE BIOREACTOR SIMULATING THE ARTIFICIAL BLOOD VESSEL

Dolata A, Ciechanowska A, Hoser G, Sabalińska S, Kawiak J, Wojciechowski C, Chwojnowski A, Ładyżyński P


P46 AN EFFECT OF THROMBIN ON PROLIFERATION OF HUVECS CULTURED ON THE FLAT SEMIPERMEABLE POLYSULFONE MEMBRANE SIMULATING THE BLOOD VESSEL WALL

Hoser G, A. Ciechanowska A, Sabalińska S, Kawiak J, Wojciechowski C, Chwojnowski A, Ładyżyński P


P47 AN ANALYSIS OF PROLIFERATION AND PRODUCTION OF VWF AND SICAM-1 BY HUVECS CULTURED IN MEMBRANE BIOREACTOR USED AS A MODEL OF ARTIFICIAL BLOOD VESSEL

Ciechanowska A, Hoser G, Sabalińska S, Kawiak J, Wojciechowski C, Chwojnowski A, Ładyżyński P


P48 THE DEVELOPMENT OF XENOGENEIC, SELF-ORGANIZING SMALL-DIAMETER VASCULAR GRAFT USING BIOTUBE MATRIX

Yamanami M1, Kawasaki T2, Kami D3, Watanabe T1, Kanda K1, Gojo S3, Yaku H1 1 Department of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; 2 Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan; 3 Department of Regenerative Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

P49 A BIOARTIFICIAL KIDNEY DEVICE FOR PROTEIN BOUND UREMIC TOXIN REMOVAL AND IMMUNOGENICITY ANALYSIS

Fedecostante M1, Chevtchik N2, Mihaijlovic M1, Stamatialis D2, Masereeuw R1 1 Pharmacology Division, Utrecht University, Utrecht, The Netherlands; 2 Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands

P50 SELECTION OF SYNTHETIC POLYMER SOLUTIONS FOR THE PRODUCTION OF PARTIALLY BIODEGRADABLE MICROCAPSULES

Kutkowska A, Grzeczkowicz M, Paziewska A, Chwojnowski A, Lewińska D


P51 GENETICALLY MODIFIED HUMAN HEPATOMA CELL LINE – C3A CHARACTERIZED BY HIGH AMMONIA TOLERANCE AS A SOURCE OF CELLS FOR BIOARTIFICIAL LIVER SUPPORT

Samluk A, Zakrzewska K, Kowalska A, Pijanowska D1, Pluta K


P52 EFFECT OF DIRECT TENSILE STRAIN ON DIFFERENTIATION OF MESENCHYMAL STEM CELLS

Campbell Ritchie A1, Moles M2, Colin S1, Sottile V3 1 Faculty of Engineering, University of Nottingham, Nottingham, UK; 2 Wolfson School of Engineering, University of Loughborough, Loughborough, UK; 3 Faculty of Medicine, University of Nottingham, Nottingham, UK

P53 MICROCOMPUTED TOMOGRAPHY (MCT) STUDY OF HOLLOW FIBER MEMBRANE (HFM) DISTRIBUTION IN HFM-BIOREACTORS IN SHELL-AND-TUBE CONFIGURATION FOR BONE TE

Falvo D’Urso Labate G1, Debbaut C2, Van Hoorebeke L3, De Schryver T3, Segers P2, Catapano G1 1 Department of Environmental and Chemical Engineer, University of Calabria, Cosensa, Italy; 2 IBiTech - BioMMeda, Ghent University, Ghent, Belgium; 3 UGCT-Rad. Phys., Dept. of Physics and Astronomy, Ghent University, Ghent, Belgium

Methods in Tissue Engineering (PS6) P54-P62

Chairmen: Dorota G. PIJANOWSKA, Warsaw, Poland, Dimitrios STAMATIALIS, Twente, The Netherlands

P54 CHECKERED MICRO CONVEXOCONCAVE PATTERN FOR ORIENTATION OF CELL CULTURE

Hashimoto S, Takahashi Y, Sugimoto K, Hino H

Mechanical Engineering, Kogakuin University, Tokyo, Japan

P55 ELECTRIC STIMULATION FOR MYOBLAST CULTURE ON MICRO COIL SPRING

Takahashi Y, Hashimoto S, Hino H, Takeda T, Noda K



47

P56 ROLE OF ZINC IN MYOGENIC DIFFERENTIATION

Mnatsakanyan H1, Rico P2, Sabater i Serra R1, Salmeron-Sanchez M3 1 Centre for Biomaterials and Tissue Engineering, Universitat Politècnica de València, Valencia, Spain; 2 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Zaragoza, Spain; 3 Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow, UK

P57 GINSENG FILMS AS MATERIALS FOR WOUND HEALING

Krylova E1, Krylov S1, Kraseninnikov M2, Oganesyan R2, Lyundup A2, Ivanov I3, Titova M3 1 IRIS, Belgorod, Russian Federation; 2 Sechenov First Moscow Sate Medical University, Moscow, Russian Federation; 3 Timiryazev Institute of Plant Physiology RAS, Moscow, Russian Federation

P58 LASER WELDING OF BIOLOGICAL TISSUES OF THE INTERNAL ORGANS OF THE DIGESTIVE SYSTEM

Savelyev M, Ryabkin D, Rimshan I, Ichkitidze L, Podgaetskiy V, Selishchev S, Gerasimenko A

Biomedical systems, MIET, Moscow, Russian Federation

P59 COMPARISON THE VIABILITY OF CELLS CULTURED ON POLYMERIC MEMBRANES PREPARED USING DIFFERENT PORE PRECURSORS

Łukowska E, Kutkowska A, Chwojnowski A, Wojciechowski C


P60 CONTROLLED INFILTRATION OF CELLS INTO SPHERICAL POLYMERIC SCAFFOLDS

Suresh S, Gryshkov O, Glasmacher B

Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover Germany

P61 ACCELERATION OF PROLIFERATION AND DIFFERENTIATION OF CELLS BY ULTRASONIC VIBRATION

Hino H, Hashimoto S, Nakajima H, Takahashi Y


P62 DEVELOPMENT OF AFFINITY-BASED DELIVERY SYSTEM FOR HEPARIN-BINDING PROTEINS

Pokholenko I1, Dubey I1, Vozianov S2, Romanenko A2, Pirogov V2, Bazalytska S2, Nikitaiev S2, Kordium V1 1 Institute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine; 2 State Institution "Institute of Urology of NAMS of Ukraine", Kyiv, Ukraine

Innovative Technologies and New Ideas (PS7) P63-P71

Chairmen: Jörg VIENKEN, Usingen, Germany, Paweł KOSTKA, Zabrze, Poland

P63 BIOMIMETIC ARTIFICIAL TONGUE FOR THE MASTICATION AND THE PERISTALSIS

Yambe T, Shiraishi Y, Inoue Y, Yamada A

PreClinical Research Center, Tohoku University, Sendai, Japan

P64 TRANSCRANIAL CEREBELLAR DIRECT CURRENT STIMULATION IN PARALYMPIC POWERLIFTERS

Trapp A, Canciglieri Junior O, Alessandro T, Rudek M

Production and Systems Engineering Graduate Program - PPGEPS, Pontifical Catholic University of Paraná, Curitiba, Brazil

P65 ENSHURING THE INFECTIOUS SAFETY OF ALLOGENEIC TISSUE-DERIVED BIOMEDICAL PRODUCTS (TBPS) TO USE IN A HOSPITAL AMBULANCE

Khubutia M1, Mironov A2, Khvatov V2, Borovkova N2, Ponomarev I2, Ponkratova A2, Abramov V1 1 Surgery, Sklifosovsky Research Institution of Emergency Care and Moscow Institution of Physics and Technology, Moscow, Russian Federation; 2 Cell and Tissue Technology, Sklifosovsky Research Institution of Emergency Care, Moscow, Russian Federation

P66 CURRENT STATUS IN JAPAN FOR TENDENCY OF INTELLECTUAL PROPERTY EVALUATION INDEX OF MEDICAL DEVICES

Akagawa E, Tatsumi E

Department of Intellectual Asset Management, National Cerebral and Cardiovascular Center, Osaka, Japan

P67 REQUIREMENTS TO SUPORT DESIGN FOR ASSISTIVE TECHNOLOGY - DFAT TO OSTOMIZED PRODUCT: SYSTEMATIC REVIEW

Okumura MLM, Canciglieri Junior O

Production and Systems Engineering Graduate Program - PPGEPS, Pontifical Catholic University of Paraná – PUCPR, Curitiba, Brazil

P68 THE EFFECT ON NERVE REGENERATION FROM INCREASED BLOOD FLOW IN THE NERVE CONTROL AREA DUE TO STELLATE GANGLION BLOCKS

Shigeno K, Kaneko M, Wakatsuki M, Shionoya I, Nakada A, Inada Y, Kanemaru S, Nakamura T

Department of Bio-Artificial Organ, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

P69 DIGITAL SCOUT IN PARASPORTS: A CASE STUDY WITH THE MEN 'S SELECTION OF GOALBALL

Trapp A, Canciglieri Junior O, Okumura M, Tosim A, Rudek M

Production and Systems Engineering Graduate Program, Pontifical Catholic University of Parana, Curitiba, Brazil

P70 SUPERCONDUCTING FILM MAGNETIC CONCENTRATOR IN THE COMBINED MAGNETIC FIELD SENSOR

Ichkitidze L, Telishev D, Shichkin N

Department of Biomedical Systems, National Research University of Electronic Technology, MIET, Moscow, Russian Federation

P71 ANTIBACTERIAL POLY (URETHYANE UREA) BY GELATIN/ALGINATE IMOMOBIZATION

Shaneh S1, Shokrolahi F1, Shokrollahi P1, Yeganeh H2 1 Biomaterials, Iran Polymer and Petrochemical Institute, Tehran, Islamic Republic of Iran; 2 Polyurethanes, Iran Polymer and Petrochemical Institute, Tehran, Islamic Republic of Iran

Poster Sessions Friday, September 16th

48

FRIDAY, September 16th

Poster Session II

15:30 – 16:30

Poster Area

Hemodialysis I (PS8) P72-P83

Chairmen: Bernd STEGMAYR, Umea, Sweden, Malgorzata DEBOWSKA, Warsaw, Poland

Posters: P88, P75, P89, P93, P81, P80, P92, P90, P91, P79, P78, P77, P76 assigned to Hemodialysis I and Hemodialysis II sessions will be presented in a form of short oral presentations in Lecture Hall B starting at 15:30.

P72 WITHDRAWN

P73 OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS (HDP) WITH OR WITHOUT SEC-HYPERPARATHYROIDISM

Yonova D, Georgieva I, Papazov V, Trendafilov I, Georgiev M, Vazelov E

Medical Faculty, Medical University, University Dialysis Center, Sofia, Bulgaria

P74 PERITONITIS WAS NOT ASSOCIATED WITH THE SURVIVAL OF PATIENTS ON PERITONEAL DIALYSIS

Dzekova-Vidimliski P1, Simeonov R2, Sikole A1 1 University Hospital of Nephrology, Skopje, The Former Yugoslav Republic of Macedonia; 2 University Hospital of Pediatric Surgery, Skopje, The Former Yugoslav Republic of Macedonia

P75 REMOVAL OF BILE ACIDS IN EXTRACORPOREAL THERAPIES: AN IN-VITRO STUDY

Hartmann J1, Harm S2 1 Health Sciences & Biomedicine, Danube University Krems, Krems, Austria; 2 Center for Biomedical Technology, Danube University Krems, Krems, Austria

P76 RELATIONSHIP BETWEEN CIRCULATING ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) AND RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IN HEMODIALYSIS (HD)

Niepolski L1, Warchoł W2, Grzegorzewska A3 1 Dialysis Center, B.Braun Avitum Poland, Nowy Tomysl, Poland; 2 Department of Biophysics, Poznan University of Medical Sciences, Poznan, Poland; 3 Department of Nephrology, Transplantology and Internal Diseases, Poznan University, Poznan, Poland

P77 EFFICACY OF LIVER SUPPORTS IN ACUTE-ON-CHRONIC LIVER FAILURE: ROLE OF THE ASSESSMENT OF LIVER FUNCTION IMPAIRMENT BEFORE TREATMENT

Marangoni R, Bellati G, Colombo A

Department of Medicine, St. Anna Hospital, Como, Italy

P78 TREATMENT OF LARGE PLASMA VOLUMES USING SPECIFIC IMMUNOADSORPTION TO DESENSITIZE ABO-INCOMPATIBLE KIDNEY-TRANSPLANT CANDIDATES

Rostaing L1, Allal A2, Del Bello A2, Salusto F3, Esposito L2, Doumerc N3, Debiols B4, Delas A5, Game X3, Kamar N2 1 Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; 2 Department of Nephrology and Organ Transplantation, CHU Toulouse Rangueil, Toulouse, France; 3 Department of Urology and Organ Transplantation, CHU Toulouse Rangueil, Toulouse, France; 4 Etablissement Français du Sang, CHU Toulouse Purpan, Toulouse, France; 5 Service d'Anatomie et Cytologie Pathologiques, CHU Toulouse Rangueil, Toulouse, France

P79 FOUR METHODS TO REDUCE EXPOSURE TO HEPARIN DURING HEMODIALYSIS

Stegmayr B, Skagerlind M

Public Health and Clinical Medicine, Umea University, Umea, Sweden

P80 REMOVAL OF DRUGS BENEFICIAL TO PATIENTS BY VARIOUS HIGH-FLUX MEMBRANES

Gebert M, Schmidt C, Hodler J, Voigt M, Boschetti-de-Fierro A, Hulko M, Krause B

Research and Development, Gambro Dialysatoren GmbH (a part of Baxter International Inc.), Hechingen, Germany

P81 DETERMINATION OF ALBUMIN REMOVAL DURING HEMODIALYSIS: INFLUENCE OF THE DIALYSATE SAMPLING METHOD

Boschetti-de-Fierro A1, Voigt M1, Hornung M2, Hulko M1, Storr M1, Beck W3, Krause B1, Lemke H4, Krieter D5 1 Research and Development, Gambro Dialysatoren GmbH, Hechingen, Germany; 2 Product Development, Gambro Dialysatoren GmbH, Hechingen, Germany; 3 Therapeutic Area, Gambro Dialysatoren GmbH, Hechingen, Germany; 4 eXcorLab GmbH, Obernburg, Germany; 5 Division of Nephrology, Department of Medicine, University of Würzburg, Würzburg, Germany

P82 FOLLOW UP OF DIABETIC PATIENTS WITH CENTRAL VENOUS CATHETERS FOR HEMODIALYSIS

Gerasimovska V1, Gerasimovska Kitanovska B2, Sikole A2 1 Department of Nephrology, University Hospital, Skopje, The Former Yugoslav Republic of Macedonia; 2 University Clinic of Nephrology, Skopje, The Former Yugoslav Republic of Macedonia

P83 ASSOCIATION BETWEEN KDIGO SUGGESTED LEVEL ACHIEVEMENT FOR SERUM CKD-MBD MARKERS AND ARTERIO-VENOUS FISTULA THROMBOSIS IN OUR HEMODIALYSIS PATIENTS

Gelev S, Gerasimovska V, Selim G, Trajceska L, Dzekova P, Sikole A

Department of Nephrology, University Hospital, Skopje, The Former Yugoslav Republic of Macedonia


49

Hemodialysis II (PS9) P84-P96

Chairmen: Joanna STACHOWSKA-PIETKA, Warsaw, Poland, Andrea REMUZZI, Milan, Italy

Posters: P88, P75, P89, P93, P81, P80, P92, P90, P91, P79, P78, P77, P76 assigned to Hemodialysis I and Hemodialysis II sessions will be presented in a form of short oral presentations in Lecture Hall B starting at 15:30.

P84 SERUM LEVELS OF SELENIUM (SE) IN PATIENTS ON HEMODIALYSIS (HD) AND PERITONEAL DIALYSIS (PD)

Yonova D1, Georgieva I1, Vazelov E1, Trendafilov I1, Papazov V1, Tsachev K2 1 Medical Faculty, Medical University, University Dialysis Center, Sofia, Bulgaria; 2 Medical Faculty, Medical University, Clinical Department of Laboratory and Immunology, Sofia, Bulgaria

P85 REDUCTION OF UREA AND INDOXYL SULPHATE CONCENTRATION DURING DIFFERENT DIALYSIS TREATMENT MODALITIES

Holmar J1, Luman M2, Arund J1, Lauri K3, Tomson R1, Tanner R1, Kalle S1, Fridolin I1 1 Department of Biomedical Engineering, Tallinn University of Technology, Tallinn, Estonia; 2 Department of Nephrology, North Estonian Medical Centre, Tallinn, Estonia; 3 Synlab Eesti OÜ, Tallinn, Estonia

P86 AN EXPERIMENTAL STUDY TO INVESTIGATE THE STEAL PHENOMENON DURING HEMODIALYSIS

Krueger U

Department of Vascular Surgery, Queen Elisabeth Hospital, Berlin, Germany

P87 EFFECTS OF WHOLE BLOOD VISOCITY CHANGES THROUGHOUT HEMODIALYSIS SESSION ON PULSE WAVE PROPAGATION: MATHEMATICAL MODELLING

Poleszczuk J1, Dębowska M1, Wójcik-Załuska A2, Dąbrowski W3, Książek A4, Załuska W4, Waniewski J1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Department of Physical Therapy and Rehabilitation, Medical University of Lublin, Lublin, Poland; 3 Department of Anesthesiology and Intensive Therapy, Medical University of Lublin, Lublin, Poland; 4 Department of Nephrology, Medical University of Lublin, Lublin, Poland

P88 PREDICTION OF SERUM POTASSIUM CONCENTRATION LEVELS DURING A WEEK-LONG HAEMODIALYSIS CYCLE USING PSEUDO-ONE COMPARTMENT MODELLING

Pietribiasi M1, Załuska A2, Załuska W3, Lindholm B4, Waniewski J1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Department of Rehabilitation and Physiotherapy, Medical University of Lublin, Lublin,Poland; 3 Department of Nephrology, Medical University of Lublin, Lublin, Poland; 4 Baxter Novum and Renal Medicine, Karolinska Institutet, Stockholm, Sweden

P89 EFFECTS OF ELEVATED GLUCOSE LEVELS ON BLOOD-RHEOLOGICAL PARAMETERS AND ITS REPERCUSSIONS ON DIALYSIS TREATMENT

Ndzengue S1, Müller M1, Vienken J2, Glasmacher B1 1 Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover Germany; 2 Nephro-Solutions AG, Hamburg, Germany

P90 HYDRODYNAMIC EVALUATION OF A CATHETER-BASED INTRAVASCULAR ROTARY BLOOD PUMP FOR ASSISTING SELECTIVE RENAL BLOOD CIRCULATION

Sumikura H1, Ohnuma K2, Hanada S3, Tsukiya T4, Mizuno T4, Homma A5, Mukaibayashi H6, Kojima K6, Takewa Y4, Tatsumi E4 1 National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; 2 Faculty of Biomedical Engineering, Toin University of Yokohama, Osaka, Japan; 3 Taisei Clinic, Osaka, Japan; 4 Department of Artificial organs, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; 5 School of Science and Engineering, Tokyo Denki University, Tokyo, Japan; 6 IWAKI Co., Ltd., Tokyo, Japan

P91 WATER TRANSPORT PATHWAYS WITH THE PROLONGED PERITONEAL EQUILIBRATION TEST (8HOURS), USING PERITONEAL SOLUTIONS WITH LACTATE, BICARBONATE, ICODEXTRIN A

Teixido-Planas J, Troya-Saborido M, Del-Rio-Lafuente M, Rubio C, Bonet J

Nephrology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

P92 INTEGRATION OF A PATIENT-DEPENDENT KINETIC MODEL AND STATISTICAL ALGORITHMS FOR THE PREVENTIVE DETECTION OF INTRA–DIALYSIS HYPOTENSION

Bianchi C1, Vito D1, Casagrande G1, Minoretti C2, Pontoriero G3, Rombolà G4, Schoenholzer C5, Costantino M1 1 Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milan, Italy; 2 Nefrologia e Dialisi, Azienda Ospedaliera Sant'Anna, Como, Italy; 3 Nefrologia e Dialisi, Azienda Ospedaliera di Lecco, Lecco, Italy; 4 Nefrologia e Dialisi, Ospedale di Circolo e Fondazione Macchi di Varese, Varese, Italy; 5 Nefrologia e Dialisi, Ospedale Regionale di Lugano (EOC), Lugano, Switzerland

P93 APPROACHING WEARABLE ARTIFICIAL KIDNEY

Bazaev N, Selishchev S


P94 DIALYSIS REGENERATION METHODS

Bazaev N, Grinval'd V, Pozhar K


P95 COMPARISON OF DIFFERENT EXPERIMENTAL SYSTEMS FOR EXAMINATION OF THE DYNAMICS OF VITAMIN B12 RELEASE FROM ALGINATE-POLYETHERSULFONE MICROCAPSULES

Grzeczkowicz M, Lewińska D


P96 PRELIMINARY RISK ANALYSIS ON AIR INFUSION IN EXTRACORPOREAL BLOOD PURIFICATION DEVICES

Neri M1, De Rossi N1, Ferrari F2, Garzotto F3, Ronco C3, Trevisani A1 1 Department of Management and Engineering, Università degli Studi di Padova, Vicenza, Italy; 2 Department of Intensive Care Unit, San Bortolo Hospital, International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy; 3 Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy


50

Biomaterials: Synthesis and Characterization (PS10) P97-P102

Chairmen: Dorota LEWINSKA, Warsaw, Poland Jose Luis GOMEZ RIBELLES, Valencia, Spain

P97 IN VITRO DEGRADATION STUDY OF THE INNOVATIVE ELASTOMER

Zawidlak-Węgrzyńska B1, EL Fray M2, Piegat A2, Gonsior M1, Kustosz R1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Polymer Institute, Biomaterials and Microbiology Technologies Dept., West Pomerania University of Technology, Szczecin, Poland

P98 SYNTHESIS OF A SUPRAMOLECULAR HEMA HYDROGEL

Maleki Esfandabadi S, Shokrolahi P, Barzin J

Biomaterials, Iran Polymer and Petrochemical Institute, Tehran, Islamic Republic of Iran

P99 SYNTHESIS OF nZnHAp-UPy FOR BONE TISSUE ENGINEERING APPLICATIONS

M.Moghadam M, Shokrollahi P, Barzin J

Biomaterials, Iran Polymer and Petrochemical Institute, Tehran, Islamic Republic of Iran

P100 POLY(ε-CAPROLACTONE)/BIOACTIVE GLASS COMPOSITE FILMS ENRICHED WITH POLYPHENOLS EXTRACTED FROM SAGE (SALVIA OFFICINALIS L.)

Dziadek M1, Dziadek K2, Ostrowska W1, Zagrajczuk B1, Menaszek E3, Cholewa- Kowalska K1 1 Department of Glass Technology and Amorphous Coatings, AGH University of Science and Technology, Cracow, Poland; 2 Department of Human Nutrition, University of Agriculture in Cracow, Cracow, Poland; 3 Department of Cytobiology, Jagiellonian University, Collegium Medicum, Cracow, Poland

P101 APPLICATION OF SYNTHETIC NANOSTRUCTURED ZEOLITE IN FABRICATION OF POROUS TISSUE ENGINEERING SCAFFOLDS

Mohammadkhani B1, Tabesh H1, Houshmand B2, Mottaghy K3 1 Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Islamic Republic of Iran; 2 Department of Periodontology, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran; 3 Institute of Physiology, RWTH Aachen University, Aachen, Germany

P102 NANO-MODIFIED MEMBRANE AND ELECTRICAL STIMULATION FOR TISSUE REPAIRING APPLICATIONS

Grzeczkowicz A, Grzeczkowicz M, Granicka L


Biomaterials: Biocompatibility (PS11) P103-P108

Chairman: Ludomira GRANICKA, Warsaw, Poland, Andrzej CHWOJNOWSKI, Warsaw, Poland

P103 POLYURETHANE BIOACTIVE SURFACE – ACRYLIC ACID AND REDV PEPTIDE IMMOBILIZATION

Kuźmińska A, Butruk–Raszeja B, Ciach T


P104 GUINEA PIG MAXIMIZATION TEST FOR A NEW ALIPHATIC-AROMATIC POLYESTER

Zawidlak-Węgrzyńska B1, Gonsior M1, Kustosz R1, Ścigała P2, Janiczak K1, Gawlikowski M1, Cieśla P1, El Fray M3, Piegat A1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Emergency and Specialty Animal Medical Center, Piekary Śląskie, Poland; 3 Polymer Institute, Biomaterials and Microbiology Technologies Dept., West Pomerania University of Technology, Szczecin, Poland

P105 POLY(L-LACTIC ACID) MEMBRANES FOR THE CONTROLLED RELEASE OF PROTEINS TO IMPROVE THE HEALING OF SKIN DISEASES.

Gallego-Ferrer G, Delmote J, Gomez-Ribelles J

Centre for Biomaterials and Tissue Engineering, Universitat Politecnica de Valencia, Valencia, Spain

P106 STUDY OF NANOSTRUCTURE AND ADHESION PROPERTIES OF ALGINATE CELL MICROCARRIERS

Agapova O, Efimov A, Safonova L, Bobrova M, Agapov I

Laboratory of Bionanotechnology, V.I.Shumakov Federal Research Center of transplantology and artificial organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation

P107 BIODEGRADABLE MEMBRANE AS A SCAFFOLD FOR ADHERENT CELLS GROWTH - PRELIMINARY REPORT

Antosiak-Iwańska M, Godlewska E, Kinasiewicz J, Granicka L


P108 USE OF POLYETHYLENEIMINE AS AN ATTACHMENT FACTOR IN HEPATIC CELLS CULTURE

Kowalska A, Zakrzewska K, Samluk A, Pijanowska D, Pluta K


Biomaterials for Bone Replacement (PS12) P109-P114

Chairmen: Gloria GALLEGO-FERRER , Valencia, Spain, Gerardo CATAPANO, Rende, Italy

P109 COATINGS ON STAINLESS STEEL 316L FOR BIOMEDICAL APPLICATIONS

Poniatowska A1, Trzaskowska P1, Juśko E2, Ciach T1 1 Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland; 2 Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland

P110 EFFECT OF MATERIALS SURFACE AND CHEMICAL PROPERTIES ON CELLS ACTIVITY AND ELASTICITY IN VITRO CHARACTERIZED WITH AFM MICROSCOPY

Zagrajczuk B1, Dziadek M1, Menaszek E2, Orzechowska B3, Cholewa-Kowalska K1, Laczka M1 1 Department of Glass Technology and Amorphous Coatings, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Cracow, Poland; 2 Department of Cytobiology, Jagiellonian University, Collegium Medicum, Cracow, Poland; 3 Department of Biophysical Microstructures, Institute of Nuclear Physics PAN, Cracow, Poland


51

P111 NEW TRANSPLANT OF KNEE-JOINT LIGAMENTS WITH COMPOSITE NANOCOATING

Gerasimenko A1, Zhurbina N1, Kurilova U1, Suetina I2, Mezentseva M2, Russu L2, Oshkukov S3, Zar V3 1 Biomedical systems, National Research University of Electronic Technology, Moscow, Russian Federation; 2 Tissue culture, N.F. Gamaley Federal Reseach Center of Epidemiology and Microbiology, Moscow, Russian Federation; 3 Traumatology and orthopedics, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russian Federation

P112 PROMOTION OF BONE REGENERATION BY UTILITZING OCTACALCIUM

PHOSPHATE AND COLLAGEN COMPOSITE IN CANINE FRONTAL

SINUS(Ⅲ)

Kaneko M, Wakatsuki M, Shigeno K, Nakada A, Nakamura T

Department of Bio-Artificial Organ, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

P113 IODINE APATITE - NEW OSTEOPLASTIC MATERIAL

Krylova E1, Krylov S1, Avvakumov I1, Agapova O2, Agapov I2 1 IRIS, Belgorod, Russian Federation; 2 Federal State Budgetary Institution “Academician V.I.Shumakov Federal Research Center of Transplantology and Artificial Organs”, Ministry of Health of the Russian Federation, Moscow, Russian Federation

P114 POLY(ε-CAPROLACTONE)-BASED COMPOSITES CONTAINING BIOACTIVE GLASS PARTICLES AND CARBON FIBERS FOR TISSUE ENGINEERING APPLICATIONS

Dziadek M1, Martínez Comesana S2, Stodolak-Zych E3, Cholewa-Kowalska K1, Zagrajczuk B1, Likus W4, Los M4, Cieslar-Pobuda A4 1 Department of Glass Technology and Amorphous Coatings, AGH University of Science and Technology, Cracow, Poland; 2 Department of Materials Engineering, University of Vigo, Pontevedra, Spain; 3 Department of Biomaterials, AGH University of Science and Technology, Cracow, Poland; 4 Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Biomaterials in Blood Contact (PS13) P115-P122

Chairmen: Birgit GLASMACHER, Hannover, Germany, Bengt LINDHOLM, Stockholm, Sweden

P115 ELECTROPOLYMERIZED POLYMER COATINGS FOR STAINLESS STEEL AND THEIR FEATURES TOWARDS BLOOD AND TISSUES

Trzaskowska P, Piechna M, Ciach T


P116 HEMOLYSIS ASSESSMENT OF AN INNOVATIVE BIOMATERIAL FOR LONG TERM IMPLANTS

Janiczak K1, Zawidlak-Węgrzyńska B1, Cieśla P1, Gawlikowski M1, EL Fray M2, Kustosz R1 1 Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland; 2 Polymer Institute, West Pomerania University of Technology, Szczecin, Poland

P117 IN VITRO HEMODYNAMICAL PERFORMANCE COMPARISON IN ENDOVASCULAR DEVICES FOR TREATING INTRACRANIAL ANEURYSMS: OUR MICROPOROUS COVERED STENT VS FLOW DIVER

Moriwaki T1, Hidaka R2, Tajikawa T3, Nakayama Y1 1 Division of Medical Engineering and Materials, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; 2 Graduate School of Science and Engineering, Kansai University, Osaka, Japan; 3 Faculty of Engineering Science, Kansai University, Osaka, Japan

P118 IMMUNOLOGICALLY UNMODIFIED AND MODIFIED VASCULAR XENOGRAFTS IN THE ONE-YEAR SURVIVAL ANIMALS – MICROSCOPIC STUDY

Kim W

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea

P119 EMERGING TREATMENTS USING AN IMPLANTABLE LARGE BORE VASCULAR ACCESS SYSTEM

Khin N1, Murphy S2, Kyung C3, Avolio A1, Lane R1 1 Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia; 2 Aerospace, Mechanical and Mechatronic Engineering, University of Sydney, Sydney, Australia; 3 AllVascular Pty Ltd, Sydney, Australia

P120 WITHDRAWN

P121 EXPANDED PTFE MEMBRANE PREPARATION FOR VASCULAR PROSTHESIS

Ranjbarzadeh-Dibazar A, Barzin J, Shokrolahi P

Biomaterial, Iran Polymer and Petrochemical Institute, Tehran, Islamic Republic of Iran

P122 WITHDRAWN

Biomeasurements, Robotics and Navigations (PS14) P123-P132

Chairmen: Anna KORZYNSKA, Warsaw, Poland, Erik A. JOHANNESSEN, Borre, Norway

P123 THREE-DIMENSIONAL NANO- AND MICROSTRUCTURAL ANALYSIS OF BIOLOGICAL OBJECTS BY SCANNING PTOBE NANOTOMOGRAPHY

Efimov A, Agapova O, Agapov I

Laboratory of Bionanotechnology, V.I.Shumakov Federal Research Center of transplantology and artificial organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation

P124 NANOMATERIAL LAYERS AS STRAIN SENSORS

Blagov E1, Gerasimenko A2, Ichkitidze L2, Pavlov A1, Petuhov V2, Podgaetsky V2, Selishchev S2, ShamanY1 1 Institute of Nanotachnology of Microelectronics of the RAS, Moscow, Russian Federation; 2 Department of Biomedical Systems, National Research University of Electronic Technology, MIET, Moscow, Russian Federation


52

P125 STIMULATION OF THE CONDUCTIVITY OF LAYERS

Blagov E1, Gerasimenko A2, Ichkitidze L2, Kitsuk E1, Pavlov A1, Podgaetsky V2, Selishchev S2, Shaman Y1 1 Institute of Nanotachnology of Microelectronics of the RAS, Moscow, Russian Federation; 2 Department of Biomedical Systems, National Research University of Electronic Technology, MIET, Moscow, Russian Federation

P126 DEVELOPMENT OF A NEW COMPACT DEVICE FOR PERSONAL MONITORING OF INR, AND THE FIRST RESULTS OF ITS USE IN PATIENTS RECEIVING ANTICOAGULANT THERAPY

Subbotovskaya A1, Seredina T2, Odintsova E3, Dolgushin S4, Tronin A2, Lifshits G5 1 Laboratory of Genetic Diagnostics, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation; 2 MBU-Technology Ltd., Novosibirsk, Russian Federation; 3 Laboratory of Repair Enzymes, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation; 4 Biomedical systems, National Research University of Electronic Technology, Moscow, Russian Federation; 5 Laboratory for Personalized Medicine, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation

P127 FIBROBLAST MORPHOLOGY PARAMETERS PROPOSED TO COMPARE INFLUENCE OF PROCESS OF VIRAL TRANSDUCTION TO LIVING CELL MORPHOLOGY

Korzyńska A1, Orero G2, Roszkowiak Ł1, Zakrzewska K1, Samluk A1, Żak J1, Pluta K1 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Molecular Biology and Research Section, Hospital de Tortosa Verge de la Cinta, IISPV, URV, Tortosa, Spain

P128 INNOVATIVE MAN-MACHINE INTERFACES FOR TELEMANIPULATION, BASED ON FEATURE EXTRACTION OF OPERATOR BIOSIGNALS FROM MEMS ACCELEROMETERS AND EMG SENSORS

Kostka P1, Nawrat Z2, Malota Z2 1 Faculty of Biomedical Engineering, Silesian University of Technology, Gliwice, Poland; 2 Foundation for Development of Cardiac Surgery, Zabrze, Poland

P129 NEW DESIGN OF SMART ACUATOR FOR COLONOSCOPE NAVIGATION

Rabie M, Yao W, Gourlay T

Biomedical Engineering Department, University of Strathclyde, Glasgow, UK

P130 PROPERTIES OF MATERIALS USED FOR ARTIFICIAL ORGANS – MOLECULAR CALCULATIONS

Klonowski W


P131 TOWARDS TEXTURE BASED SELECTIVE PROCESSING WITH REGIONS OF INTEREST FOR TISSUE MICROARRAY IMAGES

Roszkowiak Ł, Korzyńska A, Pijanowska D


P132 BIOMEASUREMENTS USING FRACTAL METHODS OF IMAGE ANALYSIS

Klonowski W, Stepien P


Computer Modelling (PS15) P133-P140

Chairmen: Krzysztof JOZWIK, Lodz, Poland, Jacek WANIEWSKI, Warsaw, Poland

P133 SLEEP BRUXISM EPISODE DETECTION SYSTEM BASED ON ECG, EMG AND HEART RATE VARIABILITY SIGNAL PROCESSING TOWARD PREVENTING BIOSTIMULATOR DEVELOPMENT

Kostka P, Tkacz E

Faculty of Biomedical Engineering, Silesian University of Technology, Gliwice, Poland

P134 MATHEMATICAL MODEL OF SHORT-TERM BLOOD PRESSURE REGULATION

Pstras L1, Thomaseth K2, Waniewski J1, Balzani I3, Bellavere F4 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Institute of Electronics, Computer and Telecommunication Engineering, National Research Council, Padua, Italy; 3 Departament of Medicine, Sant’Antonio Hospital, Padua, Italy; 4 Provincial Agency for Health Services (APSS), Trento, Italy

P135 IMPROVING HAEMOLYSIS PREDICTIONS IN VADS BY UTILISING RECIRCULATING LAGRANGIAN PARTICLE TRACKING

Yousef H1, Molteni A2, Rolland S1, Low K1, Sienz J1, Foster G2 1 ASTUTE 2020, Swansea University, Swansea, UK; 2 Calon Cardio-Technology Ltd, Swansea, UK

P136 ADDED COMPLIANCE AND RESISTANCE METHOD AS A TOOL FOR LUNG FUNCTION TESTING

Pałko KJ, Gólczewski T, Darowski M


P137 OUR VIRTUAL PATIENT IN SIMULATIONS OF THE PHENOMENA THAT OCCUR DURING THORACENTESIS

Gólczewski T, Michnikowski M, Stecka A


P138 THE RELATIONSHIP BETWEEN DEGRADATION TIME AND POROSITY IN CUBIC CERAMIC SCAFFOLDS: MODELING AND SIMULATION

Tarkesh Esfahani M1, Tabesh H1, Gholami S1, Mohamadkhani B1, Poorkhalil A2, Mottaghy K2 1 Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Islamic Republic of Iran; 2 Institute of Physiology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany


53

P139 IN-SILICO PREDICTION OF ESTRADIOL RELEASE FROM AN INTRAVAGINAL RING UTILIZING A MODIFIED FINITE ELEMENT METHOD

Ziyaee Sigaroudi A1, Tabesh H1, Jafari F1, Farzaneh F2, Mottaghy K3 1 Department of Life Sciences Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Islamic Republic of Iran; 2 Preventative Gynecology Research Center (PGRC), Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran; 3 Institute of Physiology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany

P140 COLOUR RECOGNITION AND STANDARDIZATION ALGORITHM FOR COLOUR CALIBRATION SLIDE USED IN DIGITAL PATHOMORPHOLOGY

Żak J1, Korzyńska A1, Roszkowiak Ł1, Pijanowska D1, Dawgul M1, Dudziński K1, Markiewicz T2 1 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland; 2 Faculty of Electrical Engineering, Warsaw University of Technology, Warsaw, Poland

54

AUTHORS INDEX

A

Abbasciano R, O53, O70

Abdel-Sayed S, P35

Abramov V, P65

Adorisio R, P20

Affeld K, O6, O26, O28

Agapov I, O97, P106, P113, P123

Agapova O, O97, P106, P113, P123

Aigner P, AL4, O3, O82

Akagawa E, P66

Al Halabi F, AL5, O111

Alessandro T, P64

Al-Khoury H, O109

Allal A, O74, P78

Altyntsev I, O4, O65, P5, P11, P24, P25

Amoabediny G, O127, O142

Amodeo A, O48, P18, P19, P20, P21, P23

Ando T, O21

Andrade A, P30

Andreas T, IL63 (O105)

Anissimov Y, IL62 (O104)

Anne H, O22

Antolinos Turpín CM, IL22 (O37)

Antona C, P14

Antonov S, O49

Antonowicz M, O65

Antosiak-Iwańska M, P107

Argiles A, IL19, IL36, IL70

Arsov S, O54

Arund J, P85

Asano T, O130

Asencio J, P37, P39

Ashley R, IL41

Avolio A, P119

Avvakumov I, P113

B

Bach R, IL48

Bachamanda Somesh D, P43

Bader A, O100

Badria A, O81

Balzani I, P134

Baptista P, IL44 (O93)

Barzin J, P98, P99, P121

Baudequin T, AL3

Baurmeister U, IL26 (O43)

Bazaev N, P93, P94

Bazalytska S, P62

Beck W, P81

Becker M, O99

Bedou F, O22

Behr M, O55

Bellati G, P77

Bellavere F, P134

Belyaev L, P6, P13, P28

Benkowski R, O83

Bergmeister H, IL63 (O105)

Bernini F, O119

Białkowski J, P17

Biancari F, O70

Bianchi C, O51, P92

Blagov E, P124, P125

Bobrova M, O97, P106

Bode M, O111

Boës S, O5

Bolbasov E, IL60 (O102), IL62 (O104)

Bonet J, P91

Bonn F, O125

Borovkova N, P65

Boschetti-de-Fierro A, O123, P80, P81

Bozzetto M, O9

Brandl M, O113

Brown M, IL14

Brubert J, O16

Buesen M, P15

Bühler M, IL38 (O90)

Bujok W, O44, P9

Burchielli S, O119

Burmester M, O47

Busink E, CM3

Butruk–Raszeja B, P103

Buturović-Ponikvar J, IL65

Buzas E, KL7

Bużańska L, O62

C

Cabiati M, P21

Campbell Ritchie A, P52

Canciglieri Junior O, P64, P67, P69

Carda C, O24, O63

Caruso M, O116

Casagrande G, O51, O58, O134, P92

Casanueva L, O47

Caselli C, P21

Casucci F, O9

Catapano G, IL32, O19, O20, P53

Cavalheiro A, P30

Ceelen W, O139

Chan C, O56, P27

Authors Index

55

Chan-Dominy A, O47

Chevtchik N, P49

Cholewa-Kowalska K, P100, P110, P114

Christensen D, IL30

Chuvieco S, P37, P39

Chwojnowski A, P45, P46, P47, P50, P59

Ciach T, O108, P103, P109, P115

Ciechanowska A, P45, P46, P47

Cieslar-Pobuda A, P114

Cieśla P, O18, O44, O80, O110, O112, P16, P104, P116

Claus P, O68

Colin S, P52

Colombo A, P77

Combs P, IL29

Congy-Jolivet N, O74

Constantino T, O72

Cools B, O68, O69

Cornelissen C, O141

Cornillie P, P38

Costantino M, O16, O45, O51, O58, O134, P92

Cusimano V, O132

Czak M, O66

Czerski A, P36

Czingon M, O44, P16

D

D'Alessandro C, O81

Damanik FFR, IL64 (O106)

Daniele C, P41

Danilov A, O137, P2

Darłak M, O4, O65, P5, P11, P24, P25

Darowski M, O86, O136, P23, P32, P136

D'Avenio G, P41

Dawgul M, P140

Dąbrowski W, O50, P87

De Gaetano F, O16, O45

De Rossi N, P96

De Schryver T, P38, P53

De Vos W, P38

de Zélicourt D, O5, O25

Debbaut C, O19, O20, O139, P38, P53

Debiol B, O74

Debiols B, P78

Dejanov P, O10

Del Bello A, P78

Del Cañizo J, IL42 (O92), IL44 (O93), P37, P39

Del Ry S, P21

Delas A, P78

Delcroix M, O69

Delmote J, P105

Del-Rio-Lafuente M, P91

Detrez J, P38

Dębowska M, O50, O124, P87

Di Molfetta A, IL77, O48, O117, P18, P19, P20, P21, P23

Dimitrov K, O118

Dmitrieva O, P4

Dobson G, O70

Dolata A, P45

Dolgushin S, P126

Domańska-Janik K, O62

Donato D, O19, O123

Doose C, O87

Doumerc N, O74, P78

Dreyer L, O14

Drohomirecka A, P36

Dubey I, P62

Dudziński K, O60, P140

Duijs JMGJ, IL64 (O106)

Dzekova P, O10, P83

Dzekova-Vidimliski P, P74

Dziadek K, P100

Dziadek M, P100, P110, P114

E

Efimov A, P106, P123

Eganova E, O78

Egles C, O22

Egron S, O87

Eichhorn T, IL58 (O94)

El Fray M, O18, O80, O110, P97, P104, P116

Elliott T, IL45

Eloot S, KL3, O76, O123

Enayati M, IL63 (O105)

Engel S, O57

Engels G, O54

Enmi J, O107, P44

Ensminger S, O87

Erben J, IL38 (O90)

Ernst L, P15

Esmaeilzadeh P, IL9 (O34)

Esposito L, O74, P78

Evertz F, O17

F

Faggian G, O53, O70

Falk V, O99, O100, P43

Falvo D'Urso Labate G, O19, O20, O139, P53

Famaey N, O46

Fanti D, O70

Farzaneh F, P139

Favre J, P35

Fedecostante M, P49

Fernandez I, P39

Fernandez-Lopez I, P37

Ferrari F, P96

Ferrari G, O48, O86, O117, O136, P18, P19, P20, P23

Figiel- Dąbrowska A, O62

Authors Index

56

Filatov I, P4

Filippelli S, O48, P18, P19, P20

Fiore G, P14

Fischer F, O101

Fischer M, IL59 (O95)

Fluger I, P34

Foltynski P, O129

Fonseca J, P30

Fontes P, IL43

Forriol F, O24

Foschinni G, O63

Foster G, O56, P135

Fragomeni G, O116

Fraisse A, O47

Franzese I, O53

Frei M, IL38 (O90)

Fresiello L, O117, O120, P18, P19, P23

Fridolin I, P85

Fu X, P29

Fujii Y, O13, P31

Fujita B, O87

G

Gaebler J, O26

Galán G, O63

Gallego-Ferrer G, IL7 (O32), O23, O79, P105

Gałecka K, P36

Game X, O74, P78

Gámiz-González MA, IL22 (O37)

Garcia Garcia A, AL5, O22

Garzotto F, P96

Garzón I, O63

Gautier S, O97

Gawlikowski M, O18, O27, O44, O66, O80, O110, O112, P11, P12,

P16, P104, P116

Gebert M, CM1, P80

Gelev S, O10, P83

Gelpi G, P14

Georgiev M, O49, P73

Georgieva I, P73, P84

Gerasimenko A, O78, P58, P111, P124, P125

Gerasimovska Kitanovska B, P82

Gerasimovska V, O10, P82, P83

Geremia I, O73

Gerosa G, O81

Gewillig M, O46, O68

Gföhler M, P7, P8

Ghez O, O47

Gholami S, P138

Giménez I, O61

Girndt M, IL18

Glasmacher B, O14, O17, O111, P60, P89

Glorieux G, O75

Głowacki M, O44, O112, P11, P16

Godlewska E, P107

Gojo S, P48

Golovkin A, IL60 (O102), IL62 (O104)

Gomez-Ribelles J, P105

Gonsior M, O18, O44, O65, O80, P9, P11, P16, P97, P104

Gossen M, P43

Gotier S, P4

Gottin L, O70

Gou Z, P29

Gough DA, KL5 (O88)

Gourlay T, P129

Gólczewski T, O135, O136, P136, P137

Gómez Ribelles JL, IL22 (O37), O72

Gómez-Estrada L, O23

Górczyńska K, O86, O136, P23

Graaff R, O54

Graefe R, AL2

Granegger M, CM2

Granicka L, P102, P107

Grasl C, IL63 (O105)

Grigioni M, P41

Grinval'd V, P94

Griselli M, O45

Gross C, O118, O121

Groß-Hardt S, O83, O84

Groth T, IL9 (O34)

Gryshkov O, P60

Grzeczkowicz A, P102

Grzeczkowicz M, O96, P50, P95, P102

Grzegorzewska A, O52, P76

Grzybowski A, P17

Guilbeau-Frugier C, O74

Guldris P, IL22 (O37)

Gullon L, P37, P39

Gutierrez-Gutierrez J, IL42 (O92), P37, P39

Gutowski P, O138

H

Hadimeri H, O54

Hage V, O74

Hahn A, O140

Hajek R, P34

Halbe M, IL47

Haller M, O121

Hallier S, O1

Hamming JF, IL64 (O106)

Han Q, P22

Hanada S, P90

Hanazaki K, O130

Harm S, O114, P75

Hartmann J, O113, O114, O115, P75

Hasan S, O77

Hashimoto S, P54, P55, P61

Haßler S, O55

Authors Index

57

Hawkins K, O56

Hazekamp M, O68

Heilmann A, O64, O77

Heine C, O77

Herbst C, O77

Hidaka R, P117

Hino H, P54, P55, P61

Hinteregger M, P7, P8

Hirano Y, O38

Hodler J, P80

Hoefer IE, IL64 (O106)

Holmar J, P85

Homma A, P90

Hornung M, P81

Hoser G, P45, P46, P47

Houshmand B, P101

Hovorka R, IL75

Hulko M, P80, P81

I

Iacobelli R, O48, P18, P19, P20

Ichihara Y, O29

Ichkitidze L, O78, P58, P70, P124, P125

Iida H, O107, P44

Iizuka K, O59, O67

Inada Y, P68

Inoue Y, P63

Ishii D, O107, P44

Itkin G, P4

Ivanković H, O23, O79

Ivanković M, O23, O79

Ivanov I, P57

J

Jacobs S, O30, O120

Jafari F, P139

Janeczek C, P7, P8

Janiczak K, O18, O44, O80, O110, O112, P16, P104, P116

Janiga G, O57

Janiszowski K, P1

Jankowski J, O75

Jankowski V, O75

Jaworek M, O27, P5, P14

Jockenhoevel S, O141

Jodko D, O7, P26

José María M, O72

Jost U, IL24 (O41)

Jóźwik K, O7, P26

Jung A, P40

Jungmann H, IL24 (O41)

Juśko E, P109

K

Kakinoki S, O38

Kalle S, P85

Kamar N, O74, P78

Kami D, P48

Kanda K, P48

Kaneko M, P68, P112

Kanemaru S, P68

Kapis A, O44, P9

Kappler B, O99

Karabegovic A, P7, P8

Karam B, O74

Kashefi A, O127, P33

Katagiri N, O59, O143, P31

Katsube T, O29

Kaufmann F, IL28

Kaufmann TAS, IL79, O83, O84

Kawasaki T, P48

Kawiak J, P45, P46, P47

Kazimierczak B, O60

Kellner K, O113

Kertzscher U, IL80, O6, O26, O28

Kerzenmacher S, IL38 (O90)

Khachab A, O140

Khakpour S, IL5

Khin N, P119

Khir AW, O85

Khubutia M, P65

Khvatov V, P65

Kim W, P118, P122

Kinasiewicz J, P107

Kinoshita Y, O130

Kitagawa H, O130

Kitsuk E, P125

Klammt S, IL25 (O42)

Kleinekofort W, O11

Klein-Nulend J, O142

Klonoff DC, PL4, IL71

Klonowski W, P130, P132

Klose K, P43

Knigge S, O14, O17

Kobayashi M, O21

Koewitsch A, IL9 (O34)

Kojima K, P90

Kokubo K, O12

Komagamine M, O29

Komorowska M, P36

Kong D, IL61 (O103)

Kordium V, P62

Korohoda P, P40

Korossis S, O81

Korzyńska A, P127, P131, P140

Kost J, O128

Kostka P, P128, P133

Kościelniak-Ziemniak M, O110

Authors Index

58

Koutsoukos P, O81

Kowalska A, O60, O98, P51, P108

Kozarski M, O86, O136, P23, P32

Krasheninnikov M, O97, P57

Krause B, IL35, O123, P80, P81

Kribben A, IL24 (O41)

Krieter D, O125, P81

Krisper P, P40

Krolitzki B, O14

Krueger U, P86

Kruk J, O60

Krupickova S, O47

Krylov S, P113, P57

Krylova E, P113, P57

Krzesiński G, O138

Książek A, O50, P87

Kubacki K, O44

Kunkel D, P43

Kupikowska-Stobba B, O96

Kürbitz T, O77

Kurilova U, P111

Kurisu K, O107, P44

Kurtcuoglu V, O5, O25

Kurtyka P, O4

Kusmic C, O119

Kustosz R, IL27, O4, O18, O44, O65, O66, O80, O110, O112, P5,

P9, P11, P16, P24, P25, P97, P104, P116

Kutkowska A, P50, P59

Kuźmińska A, P103

Kyung C, P119

L

L’Abbate A, O119

Laczka M, P110

Lalai RA, IL64 (O106)

Laleman W, P38

Lane R, P119

Lange F, O125

Lauri K, P85

Lavrijsen T, IL64 (O106)

Lech W, O62

Legallais C, IL3, IL40, O22

Lemke H, O125, P81

Lewandowski M, O27

Lewińska D, O96, P50, P95

Leypoldt K, O123

Li H, P22

Li S, P3

Liebsch G, IL37 (O89)

Lierath C, O15

Lifshits G, P126

Likus W, P114

Lin JT, KL5 (O88)

Lindholm B, O126, P88

Lodi M, O9

Lommel M, O28

Lomonte C, O9

Lonsky V, P34

Lopot F, O8

Los M, P114

Low K, P135

Lu C, P3

Lucarelli C, O53, O70

Lucherini F, P14

Lucisano JY, KL5 (O88)

Luman M, P85

Lyundup A, P57

Ładyżyński P, O129, O135, P45, P46, P47

Łukowska E, P59

M

M.Moghadam M, P99

Ma N, O99

Maderova K, P34

Maisano F, P35

Malashicheva A, IL60 (O102)

Malchikhina A, IL62 (O104)

Maleki Esfandabadi S, P98

Malota Z, P128

Mancini A, O53

Mano J, KL4 (O35)

Marangoni R, P77

Marijanović I, O23

Markiewicz T, P140

Martín de Llano J, O24

Martínez Comesana S, P114

Masereeuw R, P49

Mata M, O63

Matic I, O79

Matsuda K, IF3, O12

Mavrilas D, O81

Maw M, O3

Mazurczak K, O129

Mazzucco A, O70

Meboldt M, O5

Meier R, IL37 (O89)

Meisel H, O77

Menaszek E, P100, P110

Meng F, P3

Menon T, O53, O70

Menzel S, O141

Menzen C, O6

Meyns B, IL81, O30, O46, O68, O69, O117, O120

Mezentseva M, P111

Michielon G, O47

Michnikowski M, P137

Mihajlovic M, IL4, P49

Mikhalovsky S, IL34

Authors Index

59

Milián L, O24, O63

Milosevic J, O77

Mindubaev E, O137, P2

Mínguez M, O24

Minoretti C, P92

Mironov A, P65

Mishanin A, IL60 (O102)

Mitzner S, KL2, IL25 (O42), IL52, IL54

Miyamoto T, O29

Mizuno T, O67, O143, P90

Mnatsakanyan H, O39, P56

Moggridge G, O16

Mohammadkhani B, P101, P138

Moles M, P52

Molina-Mateo J, O72

Molteni A, P27, P135

Monbaliu D, P38

Morale W, O9

Moriarty C, O56

Moriguchi T, O12

Moriwaki T, P117

Moroni L, IL64 (O106)

Morozov V, P6, P13, P28

Moscato F, IL15, IL78, O3, O82, O118, O121

Motomura T, O83

Motta A, IL8 (O33)

Mottaghy K, O127, O140, O142, P33, P101, P138, P139

Mouzakis F, O127, P33

Mueller M, O14, O111

Mukaibayashi H, P90

Müller I, AL4

Müller J, O1

Müller M, P89

Munekage M, O130

Murphy S, P119

N

Naito N, O67

Nakada A, P68, P112

Nakajima H, P61

Nakamura T, P68, P112

Nakatani T, O13

Nakayama Y, O59, O107, P44, P117

Namikawa T, O130

Nawrat Z, P128

Nazari-Shafti T, O100

Ndzengue S, P89

Neidlin M, O83, O84

Neri M, P96

Neves NM, KL1 (O31)

Nevzorov A, P4

Niepolski L, P76

Nikitaiev S, P62

Nishinaka T, O29

Nishioka S, O38

Nix C, O68

Noda K, P55

Nurlidar F, O21

Nyberg S, IL10

O

Obidowski D, O7, P26

Obtułowicz P, O62

Ochsner G, O5

Odintsova E, P126

Oganesyan R, P57

Ohnuma K, P90

Okumura MLM, P67, P69

Onorati F, O53, O70

Oozawa S, O13

Orero G, P127

Orzechowska B, P110

Osaka D, O13

Oshkukov S, P111

Ostrowska W, P100

Ouwen C, P3

P

Pacholewicz J, IL17, O44

Palumbo P, O132

Pałko KJ, P23, P32, P136

Pankowska E, IL73, O129

Papazov V, P73, P84

Pauli L, O55

Pavlenko D, O71

Pavlov A, O78, P124, P125

Pawlak S, P17

Paziewska A, P50

Peeters G, P38

Pelosi G, O119

Perazzini C, O122

Peter N, O1

Petuhov V, P124

Pfeiffer D, O14

Piani D, O53

Pickup J, IL74

Piechna M, P115

Piegat A, O18, O80, P97, P104

Pieper I, O56

Piersigilli A, O119

Pietribiasi M, P88

Pijanowska D, O60, O98, P51, P108, P131, P140

Pirogov V, P62

Pitto L, P21

Pluta K, O98, P51, P108, P127

Podgaetsky V, O78, P58, P124, P125

Pokholenko I, P62

Authors Index

60

Polakovic V, O8

Poleszczuk J, O50, P87

Poniatowska A, P109

Ponikvar R, IL66

Ponkratova A, P65

Ponomarev I, P65

Pontoriero G, P92

Poorkhalil A, O127, P33, P138

Possenti L, O134

Pott D, O87

Pozhar K, P94

Preussiger M, IL24 (O41)

Pribolšan L, O23

Prikrylova K, P34

Protze S, P43

Przybylski R, P17

Pstras L, P134

Puzzuoli S, O119

Pydziński P, P12

Q

Qian W, P29

R

Rabelink TJ, IL64 (O106)

Rabie M, P129

Radley G, O56

Raes A, O76

Ragusa R, P21

Ramsauer B, O54

Ranjbarzadeh-Dibazar A, P121

Ratna Tuladhar S, O81

Ravagli E, O122

Redl H, IL63 (O105)

Rega F, O30, O46, O68, O69

Reis RL, PL3

Rekus M, O28

Remuzzi A, O9

Remuzzi G, O9

Renzulli A, O116

Reorowicz P, O7, P26

Repanas A, O14, O111

Ressler A, O79

Rico P, O39, P56

Rijnberg F, O68

Rimshan I, P58

Rivera A, P37

Rodriguez M, IL68

Rogina A, O23, O79

Rolland S, P135

Romanenko A, P62

Rombolà G, P92

Ronco C, P96

Rostaing L, O74, P78

Roszkowiak Ł, P127, P131, P140

Rota S, O9

Rothuizen TC, IL64 (O106)

Rotmans JI, IL64 (O106)

Routh TL, KL5 (O88)

Rozga J, IL13

Ródenas Rochina J, IL22 (O37)

Ruan X, P29

Rubio C, P91

Rudek M, P64, P69

Rudolph M, O64

Russu L, P111

Ruzickova J, P34

Ryabkin D, P58

S

Sabalińska S, P45, P46, P47

Sabater i Serra R, O72, P56

Safonova L, O97, P106

Saito S, O29

Salehi-Nik N, O142

Sallusto F, O74

Salmeron-Sanchez M, IL21 (O36), O39, P56

Salusto F, P78

Samluk A, O60, O98, P51, P108, P127

San Biagio L, O53, O70

Sanchez del Arco R, IL42 (O92), P37, P39

Sánchez-Romero N, O61

Sancho-Tello M, O24, O63

Sano S, O13

Santos Filho D, P30

Sauvant C, O125

Savelyev M, P58

Schettler V, IL51

Schima H, KL9, O3, O82, O118, O121

Schlatter G, O22

Schmid Daners M, O5

Schmidt C, P80

Schmidt H, IL12

Schneditz D, P40

Schneider K, IL63 (O105)

Schnurr K, IL23 (O40)

Schoenholzer C, P92

Schuele C, O6

Segers P, O19, O20, O123, O139, P38, P53

Selim G, O10, P83

Selishchev S, O2, O78, O137, P2, P58, P93, P124, P125

Senatore M, O9

Seredina T, P126

Serrani M, O16

Severi S, O122

Shagidulin M, O97

Shaman Y, P124, P125

Authors Index

61

Shaneh S, P71

Shesterikov E, IL62 (O104)

Shichkin N, P70

Shigeno K, P68, P112

Shionoya I, P68

Shiraishi Y, P63

Shokrolahi F, P71

Shokrollahi P, P71, P98, P99, P121

Shtyh D, P28

Sienz J, P135

Sierra A, P37

Siess T, O68

Siewnicka A, P1

Sikole A, O10, O54, P74, P82, P83

Simeonov R, P74

Sinev A, IL60 (O102)

Skagerlind M, P79

Snauwaert E, O76

Sonntag S, O83, O84

Soos P, O45

Soto-Gutierrez A, KL6

Sottile V, P52

Spasovski G, IL68

Speer O, O25

Spillner J, IL76

Spittler A, IL57

Stachowska-Pietka J, O126

Stadlbauer-Köllner V, P40

Stamatialis D, IL1, IL2, IL33, O71, O73, P49

Stamm C, O99, O100, P43

Stange J, IL11, IL25 (O42)

Stankiewicz B, P32

Stasiak J, O16

Stauber R, P40

Stecka A, O135, P137

Stegmayr B, IF2, IL49, IL50, O54, O75, P79

Steinseifer U, O83, O84, O87, P15

Stepien P, P132

Steuperaert M, O139

Stodolak-Zych E, P114

Storr M, O123, P81

Strobl K, O113, O115

Strusi V, IL6

Subbotovskaya A, P126

Suciu AM, O85

Suck M, O71

Suetina I, P111

Sugimoto K, P54

Sumikura H, O59, O67, P90

Suresh S, P60

Suwalski P, PL1

Suzuki S, O38

Svara F, O8

Sysoev A, P4

Szuber-Dynia A, P9

Szymanski J, IL46

Ścigała P, O18, O44, O80, P16, P104

Śliwka J, P17

Świątek M, P9

Świderska M, O52

T

Tabesh H, P33, P101, P138, P139

Taenaka Y, O143

Tajikawa T, P117

Takahashi Y, P54, P55, P61

Takeda T, P55

Takeshita D, O59

Takewa Y, IF1, O59, O67, O143, P31, P90

Tanihara M, O21

Tanner R, P85

Tarkesh Esfahani M, P138

Tateishi M, O29

Tateishi S, P31

Tatsumi E, O59, O67, O143, P31, P66, P90

Tazza L, O9

Teixido-Planas J, P91

Telyshev D, O2, O78, P70

ter Beek O, O71

Terada K, O21

Tessari M, O53, O70

Thamsen B, AL1, O26, O28

Thévenin D, O57

Thomaseth K, P134

Thormann A, O64

Thornton C, O56

Timmermans P, O120

Titova M, P57

Tkacz E, P133

Togo K, P31

Tolba R, P15

Tomson R, P85

Torbicz W, O60

Torchia F, O20

Torner B, O1

Tosim A, P69

Trajceska L, O10, P83

Trapp A, P64, P69

Trendafilov I, P73, P84

Trevisani A, P96

Tripisciano C, IL58 (O94)

Trivella M, O48, O119, P21

Trochanowska N, P36

Tronin A, P126

Troya-Saborido M, P91

Trzaskowska P, P109, P115

Tsachev K, P84

Tsukiya T, O67, O143, P90

Tverdohlebov S, IL60 (O102), IL62 (O104)

Authors Index

62

Tyczynski B, IL24 (O41)

U

Uchida H, O13

Umehara N, O29

V

Valenta R, IL56

Van Biesen W, O76

van Blitterswijk CA, IL64 (O106)

Van De Bruaene A, O69

Van Hoorebeke L, P53

Van Puyvelde J, O68

Van Raemdonck D, O69

van Zonneveld AJ, IL64 (O106)

Vande Walle J, O76

Vandecasteele T, P38

Vanholder R, IL69

Vazelov E, P73, P84

Verbelen T, O46, O69

Vermirovska J, O8

Vidaurrea A, IL22 (O37)

Vienken J, PL2, IL26 (O43), P89

Vigersky R, IL72

Vigo V, O9

Vismara R, P14

Visser MJT, IL64 (O106)

Vito D, O51, P92

Voigt M, P80, P81

Vollmer T, O75

von Segesser L, P35

Vozianov S, P62

W

Wakatsuki M, P68, P112

Walpoth BH, KL8

Walski T, P36

Walter I, IL63 (O105)

Wang I, O14

Waniewski J, IL20, O50, O124, O126, P87, P88, P134

Wanner C, O125

Warchoł W, O52, P76

Watanabe T, P48

Waterstradt K, IL23 (O40)

Wawro B, O60

Wądołowski P, O138

Wąż G, P36

Weber V, IL58 (O94), IL59 (O95)

Webster TJ, IL39 (O91)

Weiss R, IL58 (O94), IL59 (O95)

Wiecek A, IL67

Wiegmann L, O5, O25

Wierzchoń T, O65

Wilhelm M, P35

Willinger R, P7

Winiarska H, O62

Wisniewski A, O1

Witkiewicz W, P36

Witkowski D, P10, P26

Witt V, IL53, IL55

Włoczka G, P17

Wojasiński M, O108

Wojciechowski C, P45, P46, P47, P59

Wojta J, IL63 (O105)

Wójcik-Załuska A, O50, P87

Wrightson N, IL31

Wurm F, O1

X

Xu L, P3

Xu Z, O100, P3

Y

Yaku H, P48

Yamada A, P63

Yamamoto K, O12

Yamanami M, P48

Yamane K, O21

Yamane T, O12

Yamaoka T, O38

Yamazak K, O29

Yambe T, P63

Yang M, P3

Yang Y, IL9 (O34)

Yao W, P129

Yatabe T, O130

Yeganeh H, P71

Yonova D, O49, P73, P84

Yousef H, P135

Z

Zagrajczuk B, P100, P110, P114

Zakrzewska K, O60, O98, P51, P108, P127

Zalewski J, P9

Załuska A, P88

Załuska W, O50, P87, P88

Zandieh-Doulabi B, O142

Zar V, P111

Zawidlak-Węgrzyńska B, O18, O44, O80, O110, P9, P16, P97,

P104, P116

Zezula R, P34

Zhao M, IL9 (O34)

Zhao Q, IL61 (O103)

Zhdanov A, P6, P13, P28

Zhuang X, P3

Zhurbina N, P111

Authors Index

63

Zieliński K, O86, O135, O136, P23, P32

Zimpfer D, IL16, O118, O121

Ziyaee Sigaroudi A, P139

Zou J, P29

Zurriaga J, O24

Zuscich O, P34

Zweigart C, O123

Zychowicz M, O62

Żak J, P127, P140

Documents

TABLE OF - ESAO 2016 Congressesao2016.ibib.waw.pl/userfiles/ESAO_2016_Congress_Program(1).pdf · been changing and developing very fast since the last ESAO ongress in Warsaw in 2004